10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

  X   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2105 

OR

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to __________________

Commission file number 000-55323

Mentor Capital, Inc.

(Exact name of registrant as specified in its charter)

California	77-0395098
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
511 Fourteenth Street, Suite A-2, A-4, A-6, Ramona, CA 92065
(Address of principal executive offices) (Zip Code)

(760) 788-4700

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  X   No  

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes  X   No  

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-5 (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	.	Accelerated filer	.
Non-accelerated filer	. (Do not check if a smaller reporting company)	Smaller reporting company	X .

 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes  No  X   

At April 29, 2015, there were 15,668,358 shares of Mentor Capital, Inc’s common stock outstanding.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report contains “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995. All statements contained in this report other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions.  Moreover, as we begin to increase our investments in the cannabis-related industry we may be subject to heightened scrutiny and our portfolio companies may be subject to additional laws, rules, regulations, and statutes. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Registration Statement may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

You should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements.

All references in this Form 10-Q to the “Company”, “Mentor”, “we”, “us,” or “our” are to Mentor Capital, Inc.

2

MENTOR CAPITAL, INC.

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION
Item 1.	Financial Statements:	4
	Condensed Consolidated Balance Sheets – March 31, 2015 (Unaudited) and December 31, 2014	4
	Condensed Consolidated Income Statements (Unaudited) - Three months ended March 31, 2015 and 2014	6
	Condensed Consolidated Statements of Cash Flows (Unaudited) - Three months ended March 31, 2015 and 2014	7
	Notes to Condensed Financial Statements (Unaudited)	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	25
Item 4.	Controls and Procedures	26
PART II	OTHER INFORMATION
Item 1.	Legal Proceedings	27
Item 1A.	Risk Factors	28
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 3.	Defaults Upon Senior Securities	33
Item 4.	Mine Safety Disclosures	33
Item 5.	Other Information	33
Item 6.	Exhibits	33
SIGNATURES		34

3

PART I.  FINANCIAL INFORMATION

Item 1.

Financial Statements

Mentor Capital, Inc.

Condensed Consolidated Balance Sheets

		March 31,		December 31,
		2015		2014
		(Unaudited)
ASSETS
Current assets
Cash and cash equivalents	$	348,794	$	326,228
Accounts receivable, net		301,785		300,947
Prepaid expenses and other current assets		41,000		55,655
Investment in account receivable, net of discount		-		114,750
Investments in securities, at fair value		7,118		5,832
Employee advances		1,300		2,500
Total current assets		699,997		805,912
Property and equipment
Property and equipment		240,281		239,060
Accumulated depreciation and amortization		(164,978)		(157,484)
Property and equipment, net		75,303		81,576
Other assets
Receivable - Bhang Corporation and shareholders		1,500,000		1,500,000
Deposits		9,575		9,575
Convertible note receivable		105,116		104,942
Long term investments		66,355		66,203
Goodwill		1,426,182		1,426,182
Total other assets		3,107,228		3,106,902
Total assets	$	3,882,528	$	3,994,390

4

Mentor Capital, Inc.

Condensed Consolidated Balance Sheets (Continued)

		March 31,		December 31,
		2015		2014
		(Unaudited)
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Accounts payable	$	54,282	$	65,585
Accrued expenses		147,673		166,423
Line of credit		60,000		60,000
Current portion of long term debt		17,988		18,911
Total current liabilities		279,943		310,919
Long-term liabilities
Accrued salary, retirement and benefits - related party		305,154		272,982
Long term debt, net of current portion		26,985		31,249
Total long-term liabilities		332,139		304,232
Commitments and Contingencies		-		-
Shareholders' equity
Preferred stock, no par value, 100,000,000 shares
authorized; no shares issued and outstanding		-		-
Common stock, no par value, 400,000,000 shares
authorized; 14,709,951 and 14,483,215 shares issued
and outstanding at March 31, 2015 and December 31, 2014		7,101,763		7,001,908
Additional paid in capital		234,731		234,731
Accumulated deficit		(3,859,810)		(3,652,101)
Non-controlling interest		(206,238)		(205,298)
Total shareholders' equity		3,270,446		3,379,240
Total liabilities and shareholders' equity	$	3,882,528	$	3,994,390

5

Mentor Capital, Inc.

Condensed Consolidated Income Statements

For The Three Months Ended March 31, 2015 and 2014

		For the Three Months
		Ended March 31,
		2015		2014
Revenue
Service fees	$	573,850	$	490,808
Publication revenue		-		-
Other revenue		-		-
Total revenue		573,850		490,808
Cost of sales		335,913		308,380
Gross profit		237,937		182,428
Selling, general and administrative expenses		421,254		272,897
Operating income (loss)		(183,317)		(90,469)
Other income and (expense)
Gain recognized on purchase of majority interest
in WCI		-		1,250,000
Interest income		2,389		-
Interest expense		(4,000)		(4,490)
Gain (loss) on investments		1,339		1,377
Other income (expense)		-		75
Total other income and (expense)		(272)		1,246,962
Income (loss) before provision for income taxes		(183,589)		1,156,493
Provision for income taxes		-		-
Net income (loss)		(183,589)		1,156,493
Gain (loss) attributable to non-controlling interest		24,120		16,888
Net income (loss) attributable to controlling interest	$	(207,709)	$	1,139,605
Basic and diluted net income (loss) per common share:
Basic	$	(0.014)	$	0.171
Diluted	$	N/A *	$	0.171
Weighted average number of shares of common stock outstanding:
Basic		14,539,270		6,666,232
Diluted		N/A *		6,670,732

*The company recorded operating loss and so the diluted EPS will not be calculated for the diluted EPS effect is anti-dilutive.

6

Mentor Capital, Inc.

Condensed Consolidated Statements of Cash Flows

For The Three Months Ended March 31, 2015 and 2014

		For the Three Months
		Ended March 31,
		2015		2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	(183,589)	$	1,156,493
Adjustments to reconcile net income (loss) to net
cash provided by (used by) operating activities:
Depreciation and amortization		7,494		9,459
Amortization of discount on investment in account receivable		(2,250)		-
Accrued investment interest income		(326)		-
Gain recognized on purchase of majority interest in WCI		-		(1,250,000)
Decrease (increase) in operating assets
Accounts receivable - trade		(838)		22,499
Prepaid expenses and other current assets		14,655		176,990
Increase (decrease) in operating liabilities
Accounts payable		(11,303)		(22,832)
Accrued expenses		(18,750)		31,210
Accrued salary, retirement and benefits - related party		32,172		(150,899)
Net cash provided by (used by) operating activities		(162,736)		(27,080)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment		(1,221)		(3,443)
Investment in securities		(2,347)		(3,319)
Proceeds from investment in securities		1 053		-
Receivable - Bhang Chocolate Company shareholders		-		(800,000)
Receipt of investment in receivable		117,000		-
Investment in convertible note receivable		-		(100,000)
Proceeds from long term investment		-		1,150
Effect of consolidating WCI on January 1, 2014, net of cash		-		(45,921)
Employee advances repaid		1,200		1,354
Net cash provided by (used by) investing activities		115,694		(950,179)
CASH FLOWS FROM FINANCING ACTIVITIES:
Warrants converted to common stock, net of costs		99,855		3,056,120
Payments on long-term debt		(5,187)		(10,175)
Contribution by subsidiary minority interest		-		8,300
Distribution to non-controlling interest		(25,060)		(3,210)
Shares retired		-		(161)
Net cash provided by (used by) financing activities	$	69,608	$	3,050,874

7

Mentor Capital, Inc.

Condensed Consolidated Statements of Cash Flows (Continued)

For The Three Months Ended March 31, 2015 and 2014

		For the Three Months
		Ended March 31,
		2015		2014
Net change in cash	$	22,566	$	2,073,614
Beginning cash		326,228		40,184
Ending cash	$	348,794	$	2,113,798
SUPPLEMENTARY INFORMATION:
Cash paid for interest	$	1,852	$	4,000
Cash paid for income taxes	$	-	$	-
NON-CASH INVESTING AND FINANCING TRANSACTION:
Shareholder exercise of warrants by decrease in
Liability to shareholder	$	-	$	433,851
Shareholder assumption of warrant liability resulting in
Increased liability to shareholder	$	(24,074)	$	-

8

Mentor Capital, Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2015 and 2014

Note 1 - Nature of operations

History (1985 – 2008)

Mentor Capital, Inc. (“Mentor” or “the Company”) was founded as an investment partnership by the current CEO in 1985 and incorporated July 29, 1994, under the laws of the State of California. On September 12, 1996, the Company’s offering statement was qualified pursuant to Regulation A of the Securities Act, and the Company began to trade its shares publicly. On August 21, 1998, the Company filed voluntary reorganization with the bankruptcy court and, on January 11, 2000, the Company emerged from Chapter 11. The Company contracted to provide financial assistance and investment into small businesses following its reorganization.

Current Business (2008 - 2013)

Since the August 2008, name change back to Mentor Capital, Inc., the Company’s common stock has traded publicly under the trading symbol OTC Markets: MNTR.

In 2009, the Company began focusing its investing activities in leading edge cancer companies. In 2012, in response to government limitations on reimbursement for highly technical and expensive cancer treatments and a resulting business decline in the cancer development sector, the Company decided to exit that space.  In the summer of 2013 the Company was asked to consider investing in a cancer related project with a medical marijuana focus.   On August 29, 2013, the Company made a decision to divest of its cancer assets and focus all future investments in the cannabis and medical marijuana sector.   

Effective January 1, 2014, Mentor purchased an additional 1% interest in Waste Consolidators, Inc. (“WCI”) for $25,000 which resulted in a 51% ownership in WCI.  At December 31, 2013, Mentor’s investment in WCI was recorded under the equity method.  In accordance with Accounting Standard Codification 810-10, Consolidation – Overall, on January 1, 2014 Mentor remeasured its previously held equity interest at the acquisition-date fair value and recognized the resulting gain on investment in subsidiary, see Note 16.  WCI was incorporated in Colorado in 1999 and operates in Arizona.  It is a legacy investment which was acquired prior to the Company’s current focus on the cannabis sector and is included in the consolidated financial statements for the year ended December 31, 2014.

On February 18, 2014, the Company signed an agreement to purchase a 51% interest in MicroCannaBiz, LLC (“MCB”), for $200,000, see Note 11.  MCB is a Limited Liability Company organized in Florida in January 2014 which began operations in June 2014.  MCB provides cannabis and marijuana related private companies, investors and microcap issuers with information resources including client company specific publications, directories, and continuing education courses.   MCB operations are included in the consolidated financial statements for the year ended December 31, 2014.  

On February 28, 2014, the Company acquired a 60% ownership in Bhang Chocolate Company, Inc. (“Bhang”), see Note 4 regarding the purchase and subsequent Mentor lawsuit seeking rescission of the agreement.  Amounts invested in Bhang are reported as Receivable from Bhang Chocolate Company shareholders in the consolidated balance sheet at December 31, 2014 and March 31, 2015.

Note 2 - Summary of significant accounting policies

Condensed consolidated financial statements

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  The results of operations for the periods ended March 31, 2015 and 2014 are not necessarily indicative of the operating results for the full years.

Basis of presentation

The Company’s consolidated financial statements include majority owned subsidiaries of 51% or more.    The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.  All material intercompany balances and transactions have been eliminated in consolidation.

9

Note 2 - Summary of significant accounting policies (continued)

As shown in the accompanying financial statements, the Company has a significant accumulated deficit of $3,859,810 as of March 31, 2015. The Company also continues to experience negative cash flows from operations. The Company will be required to raise additional capital to fund its operations, and will continue to attempt to raise capital resources from both related and unrelated parties until such time as the Company is able to generate revenues sufficient to maintain itself as a viable entity. These factors have raised substantial doubt about the Company's ability to continue as a going concern. There can be no assurances that the Company will be able to raise additional capital or achieve profitability. However, the Company has 14.3 million warrants outstanding in which the Company can reset the exercise price substantially below the current market price, see Note 9.   These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company raised approximately $99,855 from partial warrant redemptions from February 9, 2015 through March 31, 2015, see Note 9.  In addition, from April 1, 2015 through April 22, the Company raised approximately $79,738 from the exercise of warrants into common stock.  The Company estimates it has adequate cash reserves to support six to eighteen months of operation.  Management's plans include increasing revenues through acquisition, investment, and organic growth.  This is to be funded by raising additional capital through the sale of equity securities and debt.

Concentrations of cash

The Company maintains its cash and cash equivalents in bank deposit accounts which at times may exceed federally insured limits.  The Company has not experienced any losses in such accounts nor does the Company believe it is exposed to any significant credit risk on cash and cash equivalents.  

Cash and cash equivalents

The Company considers all short-term debt securities purchased with a maturity of three months or less to be cash equivalents. The Company had no short-term debt securities as of March 31, 2015 and 2014.

Accounts receivable

Customer accounts receivable are classified as current assets and are carried at original invoice amounts less an estimate for doubtful receivables based on a review of all outstanding amounts on a monthly basis.  The estimate of allowance for doubtful accounts is based on the Company's bad debt experience, market conditions, collateral available, and aging of accounts receivable, among other factors. If the financial condition of the Company's customers deteriorates resulting in the customer's inability to pay the Company's receivables as they come due, additional allowances for doubtful accounts will be required. At March 31, 2015 and 2014, the Company has recorded an allowance in the amount of $8,700 and $0, respectively.

Investment in unconsolidated entity

Prior to acquiring a controlling interest in WCI on January 1, 2014, Mentor accounted for the investment in WCI using the equity method based on the ownership interest and the Company’s limited ability to exercise significant influence at December 31, 2013.  Accordingly, the investment was initially recorded at cost with adjustments to the carrying amount of the investment to recognize our share of the earnings or losses of the investee each reporting period.  Mentor ceased to recognize losses when our investment basis was zero.  At December 31, 2013, the WCI investment was $0.  On January 1, 2014, the Company purchased an additional 1% interest in WCI for a 51% interest, see Note 16.  

Convertible note receivable

The 5% convertible note receivable from Electrum Capital Partners, LLC is recorded at the loan amount of $100,000 plus accrued interest of $5,116 and $4,942 at March 31, 2015 and December 31, 2014.  

Long term investments

The Company’s investments in entities where it is a minority owner and does not have the ability to exercise significant influence are recorded at fair value if readily determinable.  If the fair market value is not readily determinable, the investment is recorded under the cost-method. Under this method, the Company’s share of the earnings or losses of such investee company is not included in the Company’s financial statements. The Company reviews the carrying value of its long term investments for impairment each reporting period.

10

Note 2 - Summary of significant accounting policies (continued)

Investment in account receivable, net of discount

The Company invested in an account receivable and promissory note on July 8, 2014 which was due on or before January 15, 2015.  The note was paid and extinguished in March 2015.  The investment was recorded at face value with an offsetting discount at the time purchased.  The discount was amortized to interest income over the term of the note.

Property, equipment and machinery

Property, equipment and machinery are recorded at cost.  Depreciation is computed on the straight-line and declining balance methods over the estimated useful lives of various classes of property ranging from 3 to 7 years.

Software development costs relate to development of MCB’s website and cannabis directory.  Software research and development costs are expensed as incurred.  Software development costs are subject to capitalization beginning when a product’s technological feasibility has been established and ending when a product is available for general release.  The Company capitalized website software costs incurred during period from inception (January 27, 2014) through October 31, 2014.  Upon the launch of the website and directory in October 2014, MCB began amortizing these costs on a straight line basis over 2 years.  

Expenditures for renewals and betterments are capitalized and maintenance and repairs are charged to expense.  Upon retirement or sale, the cost of assets disposed and the accumulated depreciation is removed from the accounts.  The resulting gain or loss is credited or charged to income.

Goodwill

Goodwill of $1,324,142 was derived from consolidating WCI effective January 1, 2014, see Note 16. The remaining $102,040 of goodwill relates to the 1999 acquisition of a 50% interest in WCI.  The Company accounts for its Goodwill in accordance with FASB Accounting Standards Codification 350, Intangibles – Goodwill and Other, which requires the Company to test goodwill for impairment annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable, rather than amortize. Goodwill impairment tests consist of a comparison of each reporting unit’s fair value with its carrying value. Impairment exists when the carrying amount of goodwill exceeds the implied fair value for each reporting unit. To estimate the fair value, management used valuation techniques which included the discounted value of estimated future cash flows. The evaluation of impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and are subject to change as future events and circumstances change. Actual results may differ from assumed and estimated amounts. Management determined that no impairment write-downs were required as of December 31, 2014.  There have been no changes in circumstances that would indicate an impairment at March 31, 2015.

Revenue recognition

The Company recognizes revenue in accordance with ASC 605 “Revenue Recognition”. The Company records revenue under each contract once persuasive evidence of an agreement exists, delivery has occurred or services have been rendered, the fee is fixed or determinable and collectability is reasonably assured.

Basic and diluted income (loss) per common share

Basic net income (loss) per common share (EPS) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS adjusts basic net income (loss) per common share, computed using the treasury stock method, for the effects of potentially dilutive common shares, if the effect is not antidilutive.   In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock warrants. Diluted EPS excludes all dilutive potential shares if their effect is antidilutive. Outstanding warrants that had no effect on the computation of dilutive weighted average number of shares outstanding as their effect would be antidilutive were approximately 15,198,000 and 15,210,000 as of March 31, 2015 and 2014, respectively.  There were 4,500 potentially dilutive shares outstanding at March 31, 2015 and 2014, respectively.

11

Note 2 - Summary of significant accounting policies (continued)

Income taxes

We utilize the asset and liability method of accounting for income taxes.  Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse.  A valuation is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

Generally accepted accounting principles provide accounting and disclosure guidance about positions taken by an organization in its tax returns that might be uncertain. Management considers the likelihood of changes by taxing authorities in its filed income tax returns and recognizes a liability for or discloses potential changes that management believes are more likely than not to occur upon examination by tax authorities.  

Management has not identified any uncertain tax positions in filed income tax returns that require recognition or disclosure in the accompanying financial statements.  The Company’s income tax returns for the past three years are subject to examination by tax authorities, and may change upon examination. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in interest expense.

Advertising and promotion

The Company expenses advertising and promotion costs as incurred.  Advertising and promotion costs were $27,145 and $8,075 for the three months ended March 31, 2015 and 2014, respectively.

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures.  Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from these estimates.

Fair value measurements

The Fair Value Measurements and Disclosure Topic defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal, or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  The valuation techniques maximize the use of observable inputs and minimize the use of unobservable inputs.

The Fair Value Measurements and Disclosure Topic establish a fair value hierarchy, which prioritizes the valuation inputs into three broad levels.  These three general valuation techniques that may be used to measure fair value are as follows:  Market approach (Level 1) – which uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.  Prices may be indicated by pricing guides, sale transactions, market trades, or other sources.  Cost approach (Level 2) – which is based on the amount that currently would be required to replace the service capacity of an asset (replacement cost); and the Income approach (Level 3) – which uses valuation techniques to convert future amounts to a single present amount based on current market expectations about the future amounts (including present value techniques, and option-pricing models).  Net present value is an income approach where a stream of expected cash flows is discounted at an appropriate market interest rate.

The carrying amounts of cash, accounts receivable, prepaid expenses and other current assets, accounts payable, customer deposits and other accrued liabilities approximate their fair value due to the short-term nature of these instruments.

The fair value of the note receivable is based on the net present value of calculated interest and principle payments.  The carrying value approximates fair value as interest rates charged are comparable to market rates for similar notes.

The fair value of long-term notes payable is based on the net present value of calculated interest and principle payments.  The carrying value of long-term debt approximates fair value due to the fact that the interest rate on the debt is based on market rates.  

12

Note 2 - Summary of significant accounting policies (continued)

Recent Accounting Standards

The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Note 3 – Prepaid expenses and other assets

Prepaid expenses and other assets consist of the following:

		March 31, 2015		December 31, 2014
Prepaid advertising costs	$	3,637	$	27,708
Prepaid legal fees		9,145		9,145
Other prepaid costs		28,218		28,218
	$	41,000	$	55,655

Note 4 - Acquisition of interest in Bhang Chocolate Company, Inc. and suit seeking rescission

On January 17, 2014, the Company transitioned out of its cancer related trading dormancy by announcing its first cannabis sector letter of intent amidst significantly increased share volume and price.  The Company entered into a co-operative funding agreement with Bhang Chocolate Company, Inc. on February 28, 2014, that provided for the purchase from owners of a 60% ownership in Bhang.   Mentor anticipated funding the co-operative funding agreement through unrelated debt funding.  Bhang owners were to receive $9,000,000 in consideration in the first 90 days.  During the first 90 days, $1,500,000 was provided to Bhang owners in cash from proceeds of warrant exercises.  The lending equity group was unable to fund the loan they announced.  Mentor tendered the remaining $7,500,000 to the Bhang owners in freely trading shares of Mentor Common Stock per the terms of the co-operative agreement.  The Bhang owners refused Mentor’s tender of stock.

On June 24, 2014, Bhang owners unilaterally announced that Bhang was no longer doing any business with Mentor.  Bhang failed to provide Mentor with Bhang share certificates evidencing the Bhang shares purchased by Mentor or provide other promised consideration to Mentor, effectively repudiating the co-operative agreement by their actions.  In addition, Bhang owners have declined to return any of the $1,500,000 invested by Mentor.  On August 11, 2014, Mentor filed suit against Bhang and its owners, in the United States District Court for the Northern District of California for rescission seeking return of the $1,500,000 investment the Company made in Bhang.  The parties have been ordered to undergo arbitration, which was initiated in January 2015.  The suit in the District Court has been stayed pending the outcome of arbitration, see Note 17.

Note 5 – Investment in account receivable

The investment in account receivable is supported by a promissory note which matured January 15, 2015 and consists of the following:

		March 31, 2015		December 31, 2014
Face value	$	-	$	117,000
Unamortized discount		-		(2,250)
Net balance	$	-	$	114,750

The note was paid and extinguished in March 2015.  For the three months ended March 31, 2015 and 2014, $2,250 and $0 of discount amortization is included in interest income.  

13

Note 6 - Property and equipment

Property and equipment is comprised of the following at March 31, 2015 and December 31, 2014:

		March 31, 2015		December 31, 2014
Computers	$	15,187	$	15,187
Furniture and fixtures		20,712		19,491
Machinery and vehicles		179,375		179,375
Capitalized software		25,007		25,007
		240,281		239,060
Accumulated depreciation and amortization		(164,978)		(157,484)
Net Property and equipment	$	75,303	$	81,576

Depreciation and amortization expense was $7,493 and $9,460 for the three months ended March 31, 2015 and 2014, respectively.  

Note 7 – Convertible note receivable

The Company advanced $100,000 to Electrum Partners, LLC (Electrum) as a convertible note receivable on March 12, 2014.  Accrued interest of $5,116 and $4,942 is included in the convertible note receivable balance at March 31, 2015 and December 31, 2014, respectively.  The note bears interest at 5% per annum, compounded monthly for the period from March 12, 2014 to September 12, 2015, at which point the interest will increase to 10% annual interest, compounded monthly until maturity or until it is converted to shares of equity in Electrum.  There are no payments required under the note for the period from March 12, 2014 to October 12, 2015; from October 12, 2015 to March 12, 2017 interest only payments are required; and from March 12, 2017 through March 12, 2022 payments of principal and interest in the amount of $2,289.83 per month are required.  Mentor has the option to convert the note plus any accrued interest or fees into shares of equity in Electrum at any time prior to its maturity.  

14

Note 8 – Long term investments and fair value

The Company’s financial assets contained investments that have quoted market prices in active markets, the Company uses the quoted market prices as fair value and includes these prices in the amounts disclosed in Level 1 of the hierarchy. The Company receives the quoted market prices from a third party, nationally recognized pricing service (“pricing service”). When quoted market prices are unavailable, the Company utilizes a pricing service to determine a single estimate of fair value, which is mainly for its fixed maturity investments. The fair value estimates provided from this pricing service are included in the amount disclosed in Level 2 of the hierarchy. The Company bases all of its estimates of fair value for assets on the bid price as it represents what a third party market participant would be willing to pay in an arm’s length transaction.

The hierarchy of Level 1, Level 2 and Level 3 Assets are listed as following:

	Fair Value Measurements Using Unadjusted Quoted Market Prices (Level 1)	Fair Value Measurements Using Quoted Prices for Identical or Similar Assets in Active Markets (Level 2)	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Equity Securities	Other investment	Long-Term Equity Funding Agreements
Balance at December 31, 2013	21,320	10,000	55,943
Total gains or losses
Included in earnings (or changes in net assets)	1,303	1,410	-
Purchases, issuances, sales, and settlements
Purchases	18,846	-	-
Issuances	-	-	-
Sales	(35,637)	(1,150)	-
Settlements	-	-
Balance at December 31, 2014	5,832	10,260	55,943
Total gains or losses
Included in earnings (or changes in net assets)	1,278	152	-
Purchases, issuances, sales, and settlements
Purchases	1,061	-	-
Issuances	-	-	-
Sales	(1,053)	-	-
Settlements	-	-
Balance at March 31, 2015	$                  7,118	$                 10,412	$                55,943

15

Note 9 - Common stock warrants

The Company's Plan of Reorganization provided for the creditors and claimants to receive new warrants in settlement of their claims. In 2008, the term of the warrants, initially sixteen months, was extended by the Company until May 11, 2038. Management believes that identification of a specific expiration date was merely a formality and that this was not a material change from the automatic extensions which were initially provided for by vote of the board of directors and which were being performed annually since issuance, and also because the shareholders and warrant holders were primarily the same.  The Company recorded no accounting impact as a result of the extension.

Each warrant is callable by the Company if the share price exceeds the exercise price by the lesser of $1 or 100%. The warrant holders have a minimum of 30 to 90 calendar days during which to exercise their warrants once they are called. The Company may lower the exercise price of the warrants at any time.  Similarly, the Company could, but does not anticipate, reverse splitting the stock to raise the stock price above the warrant exercise price.  The warrants are specifically not affected and do not split with the shares in the event of a reverse split.  If the called warrants are not exercised, the Company has the right to designate the warrants to a new holder in return for a $0.10 per share redemption fee payable to the original warrant holder as discussed further in Note 10.  All such changes in the exercise price of series A, B, C and D warrants were provided for by the court in the Plan of Reorganization in order to provide a mechanism for debtors to receive value.  Therefore, Management believes that the act of lowering the exercise price is not a change from the original warrant grants and the Company has not recorded an accounting impact as the result of such change in exercise prices.

Exercise prices at December 31, 2012 and subsequent lower prices for the A, B, C and D warrants are as follow:

	Series A	Series B	Series C	Series D
December 31, 2012	$     1.00	$     3.00	$     0.65	$     7.00
March 21, 2012	$     0.09	$     3.00	$     0.65	$     7.00
August 21, 2012	$     0.09	$     0.11	$     0.65	$     7.00
April 1, 2013	$     0.01	$     0.11	$     0.09	$     7.00
June 18, 2014	$           -	$     0.11	$           -	$     1.60

At November 8, 2009, the Company entered into an Investment Banking agreement with Network One Securities, LLC and a related Strategic Advisory Agreement with Lenox Hill Partners, LP with regard to a potential merger with a cancer development company.  In conjunction with those related agreements, the Company issued 81,699 Series E ($1) Warrants, 369,037 Series F ($3) Warrants, 85,579 Series G ($0.65) Warrants and 689,159 Series H ($7) Warrants, all with a 30 year life.  The warrants are subject to cashless exercise based upon the ten day trailing closing bid price preceding the exercise as interpreted by the Company.   The fair value of the warrants issued under the agreements was estimated on the date of the issuance using the Black-Scholes option pricing model.  The use of a valuation model requires the Company to make certain assumptions with respect to selected model inputs.  Expected volatility was calculated based on the historical volatility of the Company’s stock price.  The average expected life is based on the contractual term of the warrant and expected exercise behavior.  The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant.  

The following table provides the assumptions used to value the options granted and warrants issued using the Black-Scholes option pricing model:

	Series E	Series F
	and G	and H
Stock price volatility	111.60%	111.60%
Risk-free rate of return	4.26%	4.26%
Annual dividend yield	0.00%	0.00%
Expected life (in years)	0.5	3.0

As of March 31, 2015 and December 31, 2014 the weighted average contractual life for all Mentor warrants was 21.4 years and 23.4 years, respectively, and the weighted average outstanding warrant exercise price was $1.84 and $1.84 per share, respectively.

During the three months ended March 31, 2015 and 2014, a total of 1,187,847 and 8,006,696 warrants were exercised, respectively. There were no warrants issued during the periods ended March 31, 2015 and 2014.  The intrinsic value of outstanding warrants at March 31, 2015 and 2014 was $2,835 and $15,300, respectively.

16

Note 9 - Common stock warrants (continued)

The following table summarizes common stock warrants as of each period:

	Series A	Series B	Series C	Series D	A,B,C,D Total Warrants
Outstanding at December 31, 2013	1,188,909	5,332,981	128,180	15,312,627	21,962,697
Issued	-	-	-	-	-
Exercised	(1,188,909)	(5,328,481)	(128,180)	(807,861)	(7,453,431)
Outstanding at December 31, 2014	-	4,500	-	14,504,766	14,509,266
Issued	-	-	-	-	-
Exercised	-	-	-	(226,740)	(226,740)
Outstanding at March 31, 2015	-	4,500	-	14,278,026	14,282,526

Series E, F, G and H warrants were issued for investment banking and advisory services during 2009.  The following table summarizes E, F, G and H warrants as of each period:

	Series E    $1.00 exercise   price	Series F $3.00 exercise price	Series G  $0.65 exercise price	Series H  $7.00 exercise price	E,F,G,H Total Warrants
Outstanding at December 31, 2013	107,931	369,037	88,579	689,159	1,254,706
Issued	-	-	-	-	-
Exercised	(107,931)	(369,037)	(88,579)	-	(565,547)
Outstanding at December 31, 2014	-	-	-	689,159	689,159
Issued	-	-	-	-	-
Exercised	-	-	-	-	-
Outstanding at March 31, 2015	-	-	-	689,159	689,159
Shares issued in 2014 as a result of cashless exercise	73,388	210,870	70,152	-	354,410

On February 9, 2015, in accordance with the authorizing section 1145 reorganization court order, the Company announced a 30 day partial redemption of up to 1% (approximately 140,000) of the already outstanding series D warrants to provide for the court specified redemption mechanism for warrants not exercised timely by the original holder or their estates. Company designees that apply during the 30 days must pay 10 cents to redeem the warrant and then exercise the series D warrant to purchase a share at $0.435, which follows the court specified formula of one-half of the closing bid price on the day preceding the 30 days, plus the 10 cent fee. In successive months, the 1% partial redemption authorization will be recalculated and repeated according to the court formula until such unexercised warrants are exhausted or the partial redemption is otherwise truncated by the Company.  

Note 10 - Warrant redemption liability

The Plan of Reorganization provides the right for the Company to call, and the Company or its designee to redeem warrants that are not exercised timely, as specified in the Plan, by transferring a $0.10 redemption fee to the former holders. Certain individuals desiring to become a Company designee to redeem warrants have deposited redemption fees with the Company that, when warrants are redeemed, will be forwarded to the former warrant holders at their last known address 30 days after the last warrant of a class is exercised, or earlier at the discretion of the Company. The Company has arranged for a service to process the redemption fees in offset to an equal amount of liability.  

17

Note 11 - Funding agreement

The Company entered into a co-operative funding agreement with MCB that closed on February 18, 2014, to purchase up to a 51% interest in MCB.  MCB provides cannabis and marijuana related private companies, investors and microcap issuers with information resources including client company specific publications, directories, and continuing education courses.   MCB was to receive up to $200,000 in funding as Mentor receives proceeds from warrant exercise.  Allocation of funding to MCB is discretionary and could be reduced to $100,000 with no change in Mentor’s ownership if Mentor is dissatisfied with MCB performance.  Subsequent to March 31, 2015, MCB was notified that the funding would be reduced to $100,000, see Note 19.  The Company has the right, in its sole discretion, to convert the paid portion of the $100,000 equity investment in MCB to a six percent (6%) ten-year note payable to Mentor by the majority owner of MCB in 120 equal payments of principal and interest at any time.  If triggered, this provision would truncate further funding.  Subsequent to March 31, 2015, Mentor notified MCB that it was exercising its right to convert its equity to a ten-year note, see Note 19.

Note 12 - Stockholders’ equity

Common Stock

The Company has a total of 400,000,000 shares of Common Stock, no par value, authorized at March 31, 2015 and December 31, 2014. The holders of Common Stock are entitled to one vote per share on all matters submitted to a vote of the stockholders and may accumulate their votes for the election of directors. During 2007, the Company effected a 1,000 to 1 reverse stock split on its outstanding common stock, under the authority of the Plan, and subsequent to receiving 84% shareholder approval and Board of Directors approval. During September 2008, the Company announced a stock repurchase plan which allowed for a total of 12.5% of the Company’s shares outstanding at that time to be repurchased during future periods. All shares under the 2008 repurchase plan were repurchased as of January 2014.    

On August 8, 2014, the Company announced that it was initiating the repurchase of approximately 2% of the Company’s   shares outstanding at that time.  As of March 31, 2015 and December 31, 2014, 21,848 shares have been repurchased and retired.

Note 13 - Lease commitments

Operating Leases

Mentor currently rents approximately 2,000 square feet of office space on a month-to-month basis in Ramona, California in San Diego County. Rent expense for the three months ended March 31, 2015 and 2014 were $4,100 and $8,092, respectively.   

WCI rents approximately 3,000 of office and warehouse space in Tempte, Arizona under an operating lease expiring in January 2017.  Rent expense for the three months ended March 31, 2015 and 2014 was $6,540 and $6,633, respectively.    

WCI leases vehicles under a master fleet management agreement with initial terms of 4 years expiring through September 2018.  Vehicle lease expense of $21,400 and $21,811 is included in cost of sales in the consolidated income statement for the three months ended March 31, 2015 and 2014.  

The approximate remaining annual minimum lease payments under the non-cancelable operating leases existing as of December 31, 2014 with original or remaining terms over one year were as follows:

Years ending		Rental
December 31,		expense
2015	$	138,246
2016		120,204
2017		52,996
2018		15,360
	$	326,806

18

Note 14 – Long term debt and revolving line of credit  

Long term debt

		March 31, 2015		December 31, 2014
Two auto loans through Compass bank, interest at 7.99% per annum, monthly principle and interest payments of $538, maturing February 2016	$	5,688	$	7,168
Auto loan through Ford Credit, interest at 6.64% per annum, monthly principle and interest payments of $467, maturing October 2015		2,747		4,087
Auto loan through Hyundai Motor Finance, interest at 2.99% per annum, monthly principle and interest payments of $878, maturing December 2018.		36,538		38,905
Total notes payable		44,973		50,160
Less:  Current maturities		(17,988)		(18,911)
	$	26,985	$	31,249

Revolving line of credit

The Company has a $75,000 unsecured revolving line of credit with Bank of America, with interest at the bank’s prime rate plus 3% due monthly.  The line of credit matures on September 4, 2015.   At March 31, 2015 and December 31, 2014, the Company had $60,000 outstanding on the line of credit.  The line is secured by a personal guarantee of WCI’s president.

Note 15 - Accrued salary, accrued retirement and related party incentive fee

As of March 31, 2015 and December 31, 2014, the Company had an outstanding liability to its Chief Executive Officer ("CEO") as follows:

		March 31,     2015		December 31, 2014
Accrued salaries and benefits	$	721,987	$	716,055
Accrued incentive fee and bonus		190,581		190,581
Accrued retirement and other benefits		441,917		439,751
Offset by shareholder advance		(1,049,331)		(1,073,405)
	$	305,154	$	272,982

The Company agreed to advance the CEO $944,000 against the accrued liabilities due him, in January 2014, to exercise additional warrants into shares to be used as collateral for a potential loan to the Company.  The warrant exercise was a cashless transaction made solely for the benefit of the Company in its efforts to obtain financing.   

After the warrants were exercised, the CEO put 100% of his shares owned, 5,000,486 shares, in an escrow which was to guarantee the potential loan.  The loan was mutually rescinded on June 12, 2014, and the shares remain in escrow as of the audit date.  The CEO must make a public press release and post a notice on the Mentor website before he removes the shares from escrow.

As provided by Board of Director resolution in 1998, the CEO will be paid an incentive fee and a bonus which are payable in cash upon merger, resignation or termination or in installments at the CEO’s option.  The incentive fee is 1% of the increase in market capitalization based on the bid price of the Company’s stock beyond the book value at confirmation of the bankruptcy, which was approximately $260,000.  The bonus is 0.5% of the increase in market capitalization for each $1.00 increase in stock price up to a maximum of $8 per share (4%) based on the bid price of the stock beyond the book value at confirmation of the bankruptcy.  The Company recorded $0 of accrued incentive fee and bonus for each of the three months ended March 31, 2015 and 2014.

19

Note 16 - Purchase of additional equity in WCI

Effective January 1, 2014, Mentor purchased an additional 1% interest in WCI for $25,000 which resulted in a 51% ownership in WCI.  In 2013 Mentor’s investment in WCI was recorded under the equity method.  In accordance with Accounting Standard Codification 810-10, Consolidation – Overall, Mentor remeasured its previously held equity interest at the acquisition-date fair value and recognized the resulting gain of $1,250,964 on investment in subsidiary which is included in other income and expense in the consolidated statement of operations.

Cash to acquire additional 1% equity interest in WCI	$	25,000
Fair value of 50% interest (a)		1,250,000
Investment under equity method		-
Total purchase price to be allocated	$	1,275,000

(a) Estimated fair value of Mentor’s previously-held equity interest in WCI is valued at 1.25 times WCI’s projected 2014 revenue.

Purchase price allocation at 51% of WCI assets and liabilities:

WCI assets and liabilities:
Current assets	$	327,238
Property and equipment		51,239
Other assets		816,952
Current liabilities		(112,810)
Long-term debt		(1,178,977)
Net deficit		(96,358)
Mentor equity rate		51%
Mentor portion of liabilities in excess of assets		(49,143)
Goodwill		1,324,143
Net assets acquired	$	$1,275,000

Note 17 – Commitments and contingencies

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with FASB ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines than an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of March 31, 2015, the Company is not aware of any contingent liabilities that should be reflected in the accompanying financial statements.

Mentor lawsuit seeking rescission of co-operative funding agreement with Bhang

On August 11, 2014, Mentor filed suit against Bhang and its owners, in the United States District Court for the Northern District of California for rescission of the February 28, 2014 co-operative funding agreement with Bhang, seeking return of the $1,500,000 investment the Company made in Bhang.  This was in response to the June 24, 2014, unilateral announcement by Bhang that they were terminating all details of their relationship with Mentor, leaving Mentor with nothing, but declining to return any of the $1,500,000 paid to Bhang and owners by Mentor during the preceding and only four months of interaction. As directed by the court, arbitration has been initiated with the American Arbitration Association and the first administrative conference occurred in March 2015.  The Company intends to continue to vigorously pursuing return of its $1,500,000.  See Note 4.

In March 2015, Bhang and its owners filed a counterclaim against Mentor in the arbitration action.  Bhang contends it has suffered losses and should be able to keep the $1,500,000 they received from Mentor.  The final outcome of the arbitration is not known at this time.  The Company believes the counterclaim is without merit and plans to vigorously defend itself against all claims.

20

Note 17 – Commitments and contingencies (Continued)

In March 2014, the Company paid $621,250, which represented 1.75% of a prospective loan amount, in refundable fees paid for credit default insurance to a third party as required by the lender on an international loan facility.  The lender was unable to fund the loan and a cooperative exit from the loan commitment was agreed to by the parties on June 12, 2014.  The lender has released the requirement for credit default insurance and the insurance company has agreed to return the fee, however the refund has not yet been received.  On September 5, 2014, the Company filed suit in San Mateo County Superior Court against Wm. E. Fielding and Associates, Inc., the name of the account holder to whom the $621,250 was wired, for conversion and fraud seeking return of the $621,250 in credit insurance premiums that had been paid, had been promised to be returned, and which were not returned.  The defendant defaulted and the Company intends to prove its damages, take a judgment, and pursue collecting its damages from the defendant.  The Company plans to continue to vigorously pursue return of its $621,250.  The $621,250 in fees was expensed as loan costs in June 2014, pending the outcome of the suit.

Note 18 – Segment Information  

The Company is operating an acquisition and investment business.  Majority owned subsidiaries of 51% or more are consolidated.  The Company has determined that beginning in January 2014 there are two reportable segments, which are 1) the cannabis and medical marijuana segment which includes the receivable from Bhang of $1,500,000, the convertible note receivable from Electrum Partners and the operation of MCB, a subsidiary in the Cannabis and medical marijuana sector, and 2) the Company’s legacy investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their trash related operating costs.  The Company also has certain small cancer related legacy investments and an $117,000 investment in note receivable from a non-affiliated party that is included in Corporate below.  

		Cannabis and Medical Marijuana Segment		Legacy Investment		Corporate and Eliminations		Consolidated
Three months ended March 2015
Net sales	$	-	$	573 850	$	-	$	573,850
Income (loss) from operations		-		55 462		(245,316)		(183,317)
Total assets		1,626,740		1,114,834		1,140,954		3,882,528
Interest expense		-		4,774		(774)		4,000
Depreciation and amortization		-		6,810		683		7,493
Three months ended March 2014
Net sales	$	-	$	490,808	$	-	$	490,808
Income (loss) from operations		(21,551)		68,035		(136,953)		(90,469)
Total assets		1,600,927		1,122,564		1,270,899		3,994,390
Interest expense		-		4,093		397		4,490
Depreciation and amortization		-		6,091		3,369		9,460

21

Note 18 – Segment Information  (continued)

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

		Three months ended March 31
		2015		2014
Operating income (loss)	$	(183,317)	$	(90,469)
Gain recognized on purchase of majority interest in WCI		-		1,250,000
Interest income		2,389		-
Interest expense		(4,000)		(4,490)
Gain on investments		1,339		1,377
Other income		-		75
Income before income taxes	$	(183,589)	$	1,156,493

Note 19 - Subsequent events

On April 10, 2015, the Company entered into an exchange agreement whereby the Company will receive an investment in installment accounts receivable of $117,000 per year for 11 years totaling $1,287,000 in exchange for 757,059 shares of Mentor stock which were obtained through exercise of series D warrants at $1.60 per share.   

On April 20, 2015, the Company acquired 100% of a Georgia sole proprietorship, dba Investor Webcast (CAST) valued at $469,611 in exchange for 4,696 to-be-created series B convertible preferred shares of Mentor.  CAST provides cannabis related private companies, investors and microcap issuers with the best possible investor information through webcasts, conferences, email and an evolving mix of media products, investment publications, industry financial research, and by other means.  After one year, the to-be-created series B convertible preferred shares may be converted, in steps or in whole, into Mentor common shares.  The to-be-created series B convertible preferred shares will convert to Common based on the following conversion formula:  ((3.3 times CAST recurring revenue) + (20 times CAST after tax profit) divided by 2) plus cash minus liabilities, for the preceding four calendar quarters, as defined in the agreement.  

On April 13, 2015, Mentor notified MCB that the amount of funding provided by Mentor would be reduced to $100,000.  On April 27, 2015, Mentor notified MCB that it was exercising it’s option to convert it’s equity in MCB to a ten year note receivable for $74,000 from MCB as provided in the funding agreement.  The note receivable bears interest at 6% and will be payable in monthly installments.

22

Item 2.     Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion will assist in the understanding of our financial position at March 31, 2015 and the results of operations for the three months ended March 31, 2015 and 2014.  The information below should be read in conjunction with the information contained in the unaudited Condensed Consolidated Financial Statements and related notes to the financial statements included within this Quarterly Report on Form 10-Q for the three months ended March 31, 2015 and 2014 and our Annual Report on Form 10-K for the year ended December 31, 2014.

Corporate Background

Since the August 2008, name change back to Mentor Capital, Inc., the Company’s common stock has traded publicly under the trading symbol OTC Markets: MNTR.

In 2009 the Company began focusing its investing activities in leading edge cancer companies. In response to government limitations on reimbursement for highly technical and expensive cancer treatments and a resulting business decline in the cancer development sector, the Company decided to exit that space. In the summer of 2013 the Company was asked to consider investing in a cancer related project with a medical marijuana focus. On August 29, 2013, the Company made a decision to begin to divest of its cancer assets and focus on becoming a pure play in the cannabis and medical marijuana sector.

Waste Consolidators, Inc. (WCI)

WCI is a legacy investment of which the Company owned 50% in 2013 and purchased an additional 1%, effective January 1, 2014, for a 51% interest. WCI is included in the consolidated financial statements for the three months ended March 31, 2015 and 2014.

MicroCannaBiz (MCB)

On February 18, 2014, the Company signed an agreement to purchase 51% of MCB.  MCB was formed in January 2014 and began operations in June 2014.  From the date of formation through May 2014, MCB’s efforts were devoted to organization and development.  MCB provides cannabis and marijuana related private companies, investors and microcap issuers with information resources including client company specific publications, directories, and continuing education courses.  In April 2015, Mentor notified MCB that it was exercising its option to convert its equity in MCB to a ten year note receivable for $74,000 from the majority owner of MCB as provided in the funding agreement.  The note receivable bears interest at 6% and will be payable in monthly installments.

Bhang Chocolate Company, Inc.

On February 28, 2014, the Company acquired a 60% ownership in Bhang Corporation, also known as Bhang Chocolate Company, Inc., (“Bhang”), see Item 3 “Legal Proceedings” regarding repudiation of all contract obligations by Bhang and subsequent Mentor lawsuit seeking rescission of the agreement and return of invested funds. Amounts invested in Bhang are reported as Receivable from Bhang Chocolate Company and its owners in the consolidated balance sheet at December 31, 2014.

Cannabis Investor Webcast

On April 20, 2015, the Company acquired 100% of a Georgia sole proprietorship, dba Investor Webcast (CAST) valued at $469,611 in exchange for 4,696 to-be-created series B convertible preferred shares of Mentor.  CAST provides cannabis related private companies, investors and microcap issuers with the best possible investor information through webcasts, conferences, email and an evolving mix of media products, investment publications, industry financial research, and by other means.  After one year, the to-be-created series B convertible preferred shares may be converted, in steps or in whole, into Mentor common shares.  The to-be-created series B convertible preferred shares will convert to Common based on the following conversion formula:  ((3.3 times CAST recurring revenue) + (20 times CAST after tax profit) divided by 2) plus cash minus liabilities, for the preceding four calendar quarters, as defined in the agreement.  

23

Overview

Our goal is to be a pure play in the medical marijuana and social use cannabis sector.  Mentor seeks to take significant positions in medical marijuana and cannabis companies to provide public market liquidity for founders, protection for investors, funding for cannabis companies, and to incubate private cannabis companies that have the potential to be spun off as stand-alone pubic companies.  When Mentor takes a significant position in its investees it provides financial management when needed, but leaves operating control in the hands of the cannabis company founders.  Retaining control, receiving greater liquidity and working with an experienced organization to efficiently go public are three key advantages to cannabis founders working with Mentor Capital, Inc.

Because adult social use and medical marijuana opportunities often overlap, Mentor Capital participates in the legal recreational marijuana market. However, Mentor’s preferred focus is medical and the company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, reducing ocular pressures from glaucoma and blunting chronic pain.

Business Segments

We manage our operations through two operating segments, a cannabis and medical marijuana segment which is our current focus of business, and a legacy investment acquired prior to the Company’s focus in the cannabis and medical marijuana segment.  The legacy investment is in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their trash related operating costs.

Liquidity and Capital Resources

The Company’s future success is dependent upon its ability to make a return on our investments to generate positive cash flow and to obtain sufficient capital from non-portfolio-related sources.  Management believes they can raise the appropriate funds needed to support their business plan and develop an operating, cash flow positive company.

Results of Operations

Three Months Ended March 31, 2015 to the Three Months Ended March 31, 2014

Revenues

Revenue for the three months ended March 31, 2015 was $573,850 compared to $490,808 for the three months ended March 31, 2014 (“the prior year period”), an increase of $83,042.  This increase is due to an increase in WCI monthly service fees of $56,636 and an increase in other ancillary WCI service fees of $26,406.  

Selling, general and administrative expenses

Our selling, general and administrative expenses for the three months ended March 31, 2015 was $421,254 compared to $272,897 for the prior year period, an increase of $148,357.  The increase is due to the fact that the Company incurred $24,560 in audit fees in 2015, an increase in legal fees of $57,160, an increase of $29,724 in health and business insurance costs, an increase in advertising costs of $19,070, and an increase in salary and related costs of $65,618.  These increases were partially offset by a decrease in administrative costs of ($41,437), a decrease of ($4,372) in travel costs and a decrease in depreciation of ($1,966).

Other income and expense

Other income and expense, net, totaled ($272) for the three months ended March 31, 2015 compared to $1,246,962 for the prior year period, a decrease of ($1,247,234).  When the Company acquired an additional 1% in WCI on January 1, 2014, the entire investment was adjusted to fair value resulting in a non-cash gain on investment of $1,250,000 in the prior year period.  In addition gain on investments and other income was $113 lower in the three months ended March 31, 2015.  This is partially offset by an increase in interest income of $2,389 and decrease in interest expense of $490 for the three months ended March 31, 2015 compared to the prior year period.

24

Net results

The net result for the three months ended March 31, 2015 was a loss of ($207,709) or ($0.014) per common share compared to net income of $1,139,605 or $0.171 per common share in the prior year period.  This is due primarily to the $1,250,000 non-cash gain recorded on the investment in WCI for the prior year period.  The Company experienced an operating loss of ($183,317) for the three months ended March 31, 2015 and an operating loss of ($90,469) for the prior period.  Management will continue to make an effort to lower operating expenses and increase revenue and gross margin.  The Company will continue to look for acquisition opportunities to expand its portfolio in the cannabis industry in companies that are positive for operating revenue or have the potential to become positive for operating revenue.  

Changes in cash flows

At March 31, 2015, we had cash of $348,794 and a working capital of $420,054.  Operating cash outflows during the three months ended March 31, 2015 were ($162,736), inflows from investing activities were ($115,694), and inflows from financing activities were $69,608.  We are evaluating various options to raise additional funds, including loans.

Liquidity and Capital Resources

Since our reorganization, we have raised capital through warrant holder exercise of warrants for common stock.  At March 31, 2015 we had cash of $348,794 and a working capital of $420,054.  Operating cash outflows in the three months ended March 31, 2015 were ($162,736), including ($183,589) of net loss plus $7,494 of non-cash depreciation and amortization less ($2,250) of non-cash gain recognized on the amortization of the discount on investment in accounts receivable.  This is offset by the use of prepaid expenses and other current assets of $14,655 and changes in other operating assets of $954.  Cash inflows from investing activities in the three months ended March 31, 2015 were $115,694 due to receipt on investment in receivable of $117,000 less other investing activity changes of ($1,306).  Net inflows from financing activities during the three months ended March 31, 2015 were $69,608 of which $99,855 were the net proceeds received from exercise of warrants less payments on long-term debt of ($5,187) and distribution to non-controlling interest of ($25,060).  We will be required to raise additional funds through financing, additional collaborative relationships or other arrangements until we are able to raise revenues to a point of positive cash flow.     

On February 9, 2015, in accordance with the authorizing section 1145 reorganization court order, the Company announced a 30 day partial redemption of up to 1% (approximately 140,000) of the already outstanding series D warrants to provide for the court specified redemption mechanism for warrants not exercised timely by the original holder or their estates. Company designees that apply during the 30 days must pay 10 cents to redeem the warrant and then exercise the series D warrant to purchase a share at $0.435, which follows the court specified formula of one-half of the closing bid price on the day preceding the 30 days, plus the 10 cent fee. The Company announcement stated that in successive months, the 1% partial redemption authorization will be recalculated and repeated according to the court formula until such unexercised warrants are exhausted or the partial redemption is otherwise truncated by the Company.  During the period from February 9, 2015 to April 22, 2015 the Company raised $179,593 through partial redemption of outstanding Series D warrants plus warrant fees of $44,479.  We believe the partial redemptions will continue for an extended period of time.  

Disclosure About Off-Balance Sheet Arrangements

We do not have any transactions, agreements or other contractual arrangements that constitute off-balance sheet arrangements.

Item 3.         Quantitative and Qualitative Disclosures About Market Risk.

As a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information called for by this item.

25

Item 4.     Controls and Procedures

Evaluation of disclosure controls and procedures

Management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act.  In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.  In addition, the design of disclosure controls and procedures must reflect the fact that there are resources constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Based on management’s evaluation, our chief executive officer and chief financial officer concluded that, as of March 31, 2015, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our managers, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in internal control over financial reporting.

We regularly review our system of internal control over financial reporting and make changes to our processes and systems to improve controls and increase efficiency, while ensuring that we maintain an effective internal control environment.  Changes may include such activities as implementing new, more efficient systems, consolidating activities, and migrating processes.

There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2015 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.  

26

PART II – OTHER INFORMATION

Item 1.      Legal Proceedings.

On August 11, 2014, Mentor filed a complaint in Federal District Court for the Northern District of California for rescission against Bhang Chocolate Company, Inc., Bhang Corporation, Scott Van Rixel, and William Waggoner (together “Defendants”). Mentor alleges that Defendants have failed to perform their obligations under that certain Bhang Chocolate – Mentor Capital Cannabis Brands Cooperative Funding Agreement entered into by and between Bhang Chocolate Company, Inc. (“Bhang”) and Mentor (the “Bhang Agreement”), which anticipated Scott Van Rixel, William Waggoner, and other affiliates of Bhang as intended third party beneficiaries. Mentor asked the court to enforce the Company’s rescission of the Agreement and sought return of $1,500,000 paid to Bhang as consideration under the Agreement. Following several motions by Defendants to the action, the court ordered the parties to arbitration.  As directed by the court, arbitration has been initiated with the American Arbitration Association and the first administrative conference took place on March 10, 2015.  In March 2015, Bhang and its owners filed a counterclaim against Mentor in the arbitration action.  Bhang contends it has suffered losses and should be able to keep the $1,500,000 they received from Mentor.  The final outcome of the arbitration is not known at this time.  The Company believes the counterclaim is without merit and plans to vigorously defend itself against all claims.   

Bhang continues to hold the Company’s $1,500,000 investment and until the complete investment is returned Mentor will continue to list Bhang and Bhang Financial (Bhang’s financial services off-shoot into which $200,000 of Mentor’s funds were to be invested) in the Mentor portfolio.  Mentor anticipates one of two outcomes with this matter: (i) Bhang returns the entirety of Mentor’s investment, plus interest, at which point Bhang will no longer be listed in the Mentor portfolio, or (ii) Mentor is awarded a security interest in Bhang, in which case Bhang will be listed as a Mentor portfolio company.  Until the matter is resolved, Mentor considers the $1,500,000 invested in Bhang as an event for which it must make periodic disclosures.

On September 5, 2014, Mentor filed a complaint in California Superior Court, County of San Mateo against WM. E. Fielding and Associates, Inc. and several Doe defendants alleging causes of action for fraud and conversion associated with a wire transfer of $621,250 ostensibly to cover the purchase price of a refundable loan insurance premium for a loan Mentor was seeking. When the loan was not funded Mentor sought a return of the wired amounts but, as of yet, the funds have not been returned.  Mentor is currently in the process of seeking a default judgment against Wm. E. Fielding and Associates, Inc.  

27

Item 1A.     Risk Factors.

In addition to other information in this Quarterly Report on Form 10-Q, the following risk factors should be carefully considered in evaluating our business since it operates in a highly changing and complex business environment that involves numerous risks, some of which are beyond our control. The following discussion highlights a few of these risk factors, any one of which may have a significant adverse impact on our business, operating results and financial condition. As a result of the risk factors set forth below and elsewhere in this Form 10-Q, and the risks discussed in our Rule 15c2-11 and other publicly disclosed submissions, actual results could differ materially from those projected in any forward-looking statements.

We face significant risks, and the risks described below may not be the only risks we face. Additional risks that we do not know of or that we currently consider immaterial may also impair our business operations. If any of the events or circumstances described in the following risks actually occurs, our business, financial condition or results of operations could be harmed and the trading price of our common stock could decline.

We may not be able to continue as a going concern.

The opinion of our independent registered accounting firms included an explanatory paragraph in their reports in connection with our consolidated financial statements included with our December 31, 2014 Form 10-K as of and for the periods ended December 31, 2014 and 2013 stating that there was substantial doubt about our ability to continue as a  going  concern.  During such periods we experienced significant operating losses ($260,899 for the year ended December 31, 2013 and $1,086,198 for the year ended December 31, 2014), liquidity constraints and negative cash flows from operations.  We anticipate that current cash resources will be sufficient for us to execute our business plan through the end of the first quarter of 2016.  If we are unable to make a return on our investments to generate positive cash flow and cannot obtain sufficient capital from non-portfolio-related sources to fund operations and pay liabilities in a timely manner, we may have to cease our operations. Securing additional sources of financing to enable us to continue the investing in the cannabis and medical fields will be difficult and there is no assurance of our ability to secure such financing.  A failure to obtain additional financing and generate positive cash flow from operations could prevent us from making expenditures that are needed to pay current obligations, allow us to hire additional personnel and continue to seek out and invest in new technology and service companies. This leaves doubt as to our ability to continue as a going concern.

Management has a lack of experience operating as a fully reporting company and meeting the associated reporting obligations.

Management has operated Mentor Capital, Inc. as a non-reporting public company for 20 years, but only recently has voluntarily transitioned to reporting company status subject to financial and other SEC required disclosures.  Prior to such voluntary transition, Management has not been required to prepare and make such required disclosures. As a reporting company we will be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (“Exchange Act”), the Sarbanes-Oxley Act, the Dodd-Frank Act, the listing requirements of a national securities exchange, and other applicable securities rules and regulations.  The Exchange Act requires, among other things, that we file annual, quarterly, and current reports with respect to our business and operating activities.  As Management has never before been required to prepare and file these disclosure reports, doing so may impose a significant expense, time and reporting burden upon management.  This distraction can divert management from its operation of the business to the detriment of core operations. Also, improper reporting due to inexperience can result in trading restrictions and other sanctions that may impair or even suspend trading in the company common stock.

Investors may suffer risk of dilution following exercise of warrants for cash.

As of March 31, 2015, The Company currently had 14,709,951 outstanding shares of its Common Stock trading at approximately $0.73 per share.  As of the same date the Company also had 14,278,026 outstanding Series D warrants exercisable for shares of Common Stock at $1.60 per share.  These Series D warrants do not have a cashless exercise feature.  The Company anticipates that the warrants will not be exercised until the per share price of the Company’s Common Stock is greater than $1.60 per share. Exercise of these Series D warrants may result in immediate and potentially substantial dilution to current holders of the Company’s Common Stock.  The Company also has 689,159 outstanding Series H warrants with a per share exercise price of $7.00 held by an investment bank.  These $7.00 Series H warrants include a cashless exercise feature.  Current and future shareholders may suffer dilution of their investment and equity ownership if any of the warrant holders elect to exercise their warrants.

28

Beginning on February 9, 2015, in accordance with the authorizing section 1145 reorganization court order, the Company announced that it will allow for partial redemption of up to 1% per month of the outstanding series D warrants to provide for the court specified redemption mechanism for warrants not exercised timely by the original holder or their estates.  Company designees that apply during the 30 days must pay 10 cents to redeem the warrants and then exercise the series D warrant to purchase a share at one-half of the closing bid price on the day preceding the 30 days.  The 1% partial redemption will be recalculated and repeated according to the court formula until such unexercised warrants are exhausted or the partial redemption is otherwise truncated by the Company.

We operate in a turbulent market populated by businesses that are highly volatile.

The US market for cannabis products is highly volatile. While we believe that it is an exciting and growing market, many companies involved in cannabis products and services used to be involved in illegal activities, some still are, and many of them operate in unconventional ways. Some of these differences which represent challenges to us include not keeping appropriate financial records, not having access to customary business banking relationships, not having quality manufacturing relationships, and not having customary distribution arrangements. Any one of these challenges, if not managed well, could materially adversely impact our business.

Many cannabis activities, products, and services still violate law.

The legal patchwork to which cannabis companies are subject is still evolving and frequently uncertain. While we believe that anti-cannabis laws are softening and that the trend is toward legalization of cannabis products, many states and the US government still view all cannabis activity as illegal. Notwithstanding this uncertainty we intend to do our best to engage in activities that are unambiguously legal and to use what influence we have with our affiliates for them to do the same.  But we will not always have control over those companies with whom we do business and there is a risk that we could suffer a substantial and material loss due to routine legal prosecution.  Similarly many jurisdictions have adopted so-called “zero tolerance” drug laws and laws prohibiting sale of what is considered drug paraphernalia.  If our, or our affiliates activities related to cannabis activities, products, and services are deemed to violate one or more federal or state laws, we may be subject to civil and criminal penalties, including fines, impounding of cannabis products, and seizure of our assets.

Our business model is to partner with or acquire other companies.

We do not manufacture or sell cannabis products or services. Rather we try to find cannabis businesses whose products, managers, technology or other factors we like and invest in or acquire those businesses. There is no certainty that we will find suitable partners or that we will be able to engage in transactions on advantageous terms with partners we identify. There is also no certainty that we will be able to consummate a transaction on favorable terms, or any transaction at all, with any potential cannabis related acquisitions or that our partners will be able to navigate the maze of cannabis laws that may affect them. To date one of our acquisitions/investments (in Bhang Chocolate Company) has not turned out well for us, and an effort to secure a $35 million loan has resulted in a $621,250 loss.

Our actual results could differ materially from those anticipated in our forward-looking statements.

This Form 10-Q contains forward-looking statements within the meaning of the federal securities laws that relate to future events or future financial performance. When used in this report, you can identify forward-looking statements by terminology such as “believes,” “anticipates,” “plans,” “predicts,” “expects,” “estimates,” “intends,” “will,” “continue,” “may,” “potential,” “should” and similar expressions. These statements are only expressions of expectation. Our actual results could, and likely will, differ materially from those anticipated in such forward-looking statements as a result of many factors, including those set forth above and elsewhere in this report and including factors unanticipated by us and not included herein. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy and completeness of these statements. Accordingly, we caution readers not to place undue reliance on these statements. Where required by applicable law, we will undertake to update any disclosures or forward-looking statements.

29

A failure to obtain financing could prevent us from executing our business plan or operate as a going concern.

We anticipate that current cash resources will be sufficient for us to execute our business plan for the foreseeable future. However, it is possible that if future financing is not obtained we will not be able to continue to operate as a going concern. We believe that securing additional sources of financing will be difficult and there is no assurance of our ability to secure such financing. A failure to obtain additional financing could prevent us from making necessary expenditures for advancement and growth, to partner with more cannabis businesses, and to hire additional personnel. If we raise additional financing by selling equity or convertible debt securities, the relative equity ownership of our existing investors could be diluted or the new investors could obtain terms more favorable than previous investors. If we raise additional funds through debt financing, we could incur significant borrowing costs and be subject to adverse consequences in the event of a default.

If we are unable to protect our intellectual property, our competitive position would be adversely affected.

We, and our partners and subsidiaries, intend to rely on patent protection, trademark and copyright law, trade secret protection and confidentiality agreements with our employees and others to protect our intellectual property. Despite our precautions, unauthorized third parties may copy our products and services or reverse engineer or obtain and use information that we regard as proprietary. In addition, the laws of some foreign countries do not protect proprietary rights to the same extent as do the laws of the United States. Our means of protecting our proprietary rights may not be adequate and third parties may infringe or misappropriate our patents, copyrights, trademarks and similar proprietary rights. If we fail to protect our intellectual property and proprietary rights, our business, financial condition and results of operations would suffer. We believe that we do not infringe upon the proprietary rights of any third party, and no third party has asserted an infringement claim against us. It is possible, however, that such a claim might be asserted successfully against us in the future. We may be forced to suspend our operations to pay significant amounts to defend our rights, and a substantial amount of the attention of our management may be diverted from our ongoing business, all of which would materially adversely affect our business.

We are engaged in litigation.

In the past several months we have initiated two lawsuits; one against Bhang Chocolate Company and its affiliates to recover a $1,500,000 investment following Bhang’s refusal to perform its obligations, and one against the owner of a bank account into which we wired $621,250 as part of an effort to secure a $35 million loan. There is no surety that we will prevail in either of these lawsuits.

We depend on our key personnel and may have difficulty attracting and retaining the skilled staff we need to execute our growth plans.

Our success will be dependent largely upon the personal efforts of our Chief Executive Officer, Chester Billingsley and other senior managers. The loss of key staff could have a material adverse effect on our business and prospects. To execute our plans, we will have to retain current employees. Competition for recruiting and retaining highly skilled employees with technical, management, marketing, sales, product development and other specialized training is intense. We may not be successful in retaining such qualified personnel. Specifically, we may experience increased costs in order to retain skilled employees. If we are unable to retain experienced employees as needed, we would be unable to execute our business plan.

30

Founder and CEO Chet Billingsley, along with other members of the Company Board of Directors, have considerable control over the company through their aggregate ownership of 31.33% of the outstanding shares of the Company’s Common Stock on a fully diluted basis.

Mr. Billingsley owns approximately 25% of the outstanding shares of the Company’s Common Stock on a fully diluted basis.  Together with other members of the Company’s Board of Directors, Management of the Company owns approximately 31.51% of the outstanding shares of the Company’s Common Stock on a fully diluted basis.  Mr. Billingsley also holds 2,137,684 Series D warrants and 4,500 Series B warrants which are exercisable at $1.60 and $0.11 per share, respectively.  Additionally, Robert Meyer, Stan Shaul, Earl Kornbrekke and Lori Stansfield, directors of the Company, hold an aggregate of 1,195,650 Series D warrants exercisable at $1.60 per share.  Due to the large number of shares of Common Stock owned by the Management of the Company, Management has considerable ability to exercise control over the Company and matters submitted for shareholder approval, including the election of directors and approval of any merger, consolidation or sale of substantially all of the assets of the Company.  Additionally, due to his position as CEO and director, Mr. Billingsley has the ability to control the management and affairs of the Company.  As board members and officers, Mr. Billingsley and the other persons in management positions of the Company owe a fiduciary duty to our shareholders and must act in good faith in a manner each reasonably believes to be in the best interests of our shareholders. As shareholders, Mr. Billingsley and the other officers and directors are entitled to vote their shares in their own interests, which may not always be in the interests of our shareholders generally.

We face rapid change.

The market for our partners’ and subsidiaries’ products and services is characterized by rapidly changing law and technologies, marketing efforts, and extensive research and the introduction of new products and services. We believe that our future success will depend in part upon our ability to continue to develop and enhance products and services offered in the cannabis market. As a result, we expect to continue to make investments in engineering and research and development. There can be no assurance that we will be able to develop and introduce new products and services or enhance initial products in a timely manner to satisfy customer needs, achieve market acceptance or address technological changes in our target markets. Failure to develop products and services and introduce them successfully and in a timely manner could adversely affect our competitive position, financial condition and results of operations.

If we experience rapid growth, we will need to manage such growth well.

We may experience substantial growth in the size of our staff and the scope of our operations, resulting in increased responsibilities for management. To manage this possible growth effectively, we will need to continue to improve our operational, financial and management information systems, will possibly need to create departments that do not now exist, and hire, train, motivate and manage a growing number of staff. Due to a competitive employment environment for qualified technical, marketing and sales personnel, we expect to experience difficulty in filling our needs for qualified personnel. There can be no assurance that we will be able to effectively achieve or manage any future growth, and our failure to do so could delay product development cycles and market penetration or otherwise have a material adverse effect on our financial condition and results of operations.

We could face product liability risks and may not have adequate insurance.

Our partners’ and affiliates’ products may be used for medical purposes. We may become the subject of litigation alleging that our products were ineffective or unsafe. Thus, we may become the target of lawsuits from injured or disgruntled customers or other users. We intend to carry product and liability insurance, but in the event that we are required to defend more than a few such actions, or in the event our products are found liable in connection with such an action, our business and operations may be severely and materially adversely affected.

31

There is a limited market for our common stock.

Our common stock is not listed on any exchange and trades on the OTC Markets OTCQB system. As such, the market for our common stock is limited and is not regulated by the rules and regulations of any exchange. Further, the price of our common stock and its volume in the market may be subject to wide fluctuations. Our stock price could decline regardless of our actual operating performance, and stockholders could lose a substantial part of their investment as a result of industry or market-based fluctuations. Our stock trades relatively thinly. If a more active public market for our stock is not sustained, it may be difficult for stockholders to sell shares of our common stock. Because we do not anticipate paying cash dividends on our common stock for the foreseeable future, stockholders will not be able to receive a return on their shares unless they are able to sell them. The market price of our common stock will likely fluctuate in response to a number of factors, including but not limited to, the following:

·

sales, sales cycle and market acceptance or rejection of our affiliates’ products;

·

our ability to engage with partners who are successful in selling products;

·

economic conditions within the cannabis industry;

·

development of law related to cannabis products and services;

·

the timing of announcements by us or our competitors of significant products, contracts or acquisitions or publicity regarding actual or potential results or performance thereof; and

·

domestic and international economic, business and political conditions.

We have a long business and corporate existence.

We began in Silicon Valley in 1985 as a limited partnership and operated as Mentor Capital, LP until we incorporated as Main Street Athletic Clubs, Inc. in California in 1994. We were privately owned until September 1996, at which time our common stock began trading on the Over The Counter Pink Sheets. Our merger and acquisition and business development activities have spanned many business sector and we went through a bankruptcy reorganization in 1998.

Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 could have a material adverse effect on our stock price.

Section 404 of the Sarbanes-Oxley Act of 2002 and the related rules and regulations of the SEC require annual management assessments of the effectiveness of our internal control over financial reporting and a report by our independent registered public accounting firm on these internal controls. If we fail to adequately maintain compliance with, or maintain the adequacy of, our internal control over financial reporting, as such standards are modified, supplemented or amended from time to time, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 and the related rules and regulations of the SEC. If we cannot favorably assess, or our independent registered public accounting firm is unable to provide an unqualified attestation report on the effectiveness of our internal controls over financial reporting, investor confidence in the reliability of our financial reports may be adversely affected, which could have a material adverse effect on our stock price.

We have indemnified our officers and directors.

We have indemnified our Officers and Directors against possible monetary liability to the maximum extent permitted under California law.

The fragile state of the worldwide economy could impact the company in numerous ways.

The effects of negative worldwide economic events has caused disruptions and extreme volatility in global financial markets, increased rates of default and bankruptcy, has impacted levels of consumer spending, and may impact our business, operating results, or financial condition. The ongoing worldwide economic crisises, weakness in the credit markets and significant liquidity problems for the financial services industry may also impact our financial condition in a number of ways. For example, current or potential customers may delay or decrease spending with us or may not pay us or may delay paying us for previously purchased products and services. Also, we may have difficulties in securing additional financing.

32

Item 2.       Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3.       Defaults Upon Senior Securities and Use of Proceeds.

None.

Item 4.       Mine Safety Disclosures.

None.

Item 5.       Other Information.

None.

Item 6. Exhibits.

The following exhibits are filed as part of this report:

Exhibit Number	Description
31.1	Certification of the Chief Executive Officer required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of the Chief Financial Officer required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	XBRL Exhibits

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Mentor Capital, Inc.     

Date: May 13, 2015

By:

/s/ Chester Billingsley     

Chester Billingsley,

Chief Executive Officer

Date: May 13, 2015

By:

/s/ Lori Stansfield     

Lori Stansfield,

Chief Financial Officer

34

EX-31.1

Exhibit 31.1

CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Chester Billingsley, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Mentor Capital, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 13, 2015
		/s/ CHESTER BILLINGSLEY
		Chester Billingsley
		Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Lori Stansfield, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Mentor Capital, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 13, 2015
		/s/ LORI STANSFIELD
		Lori Stansfield
		Chief Financial Officer
		(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Chester Billingsley, Chief Executive Officer of Mentor Capital, Inc. (Company), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

·

the Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2015 (Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

·

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date:	May 13, 2015
		/s/ CHESTER BILLINGSLEY
		Chester Billingsley
		Chief Executive Officer
		(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Lori Stansfield, Chief Financial Officer of Mentor Capital, Inc. (Company), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

·

the Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2015 (Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

·

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date:	May 13, 2015
		/s/ LORI STANSFIELD
		Lori Stansfield
		Chief Financial Officer
		(Principal Financial Officer)

XML

Prepaid expenses and other assets (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Prepaid expenses and other assets Details
Prepaid advertising costs	$ 3,637	$ 27,708
Prepaid legal fees	9,145	9,145
Other prepaid costs	28,218	28,218
Prepaid expenses and other current assets	$ 41,000	$ 55,655

XML

Lease Commitments (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Lease Commitments Details
Rent expense paid for office space in Ramona, California	$ 4,100	$ 8,092
WCI rents office and warehouse space in Tempte, Arizona and rent expenses paid	6,540	6,633
WCI leases vehicle - vehicle lease expense included in cost of sales	$ 21,400	$ 21,811

XML

Assumptions used to value the options granted and warrants issued using the Black-Scholes option pricing model (Details)	3 Months Ended
	Mar. 31, 2015
Series E and G
Stock price volatility	111.60%
Risk-free rate of return	4.26%
Annual dividend yield	0.00%
Expected life (in years)	0.5
Series F and H
Stock price volatility	111.60%
Risk-free rate of return	4.26%
Annual dividend yield	0.00%
Expected life (in years)	3.0

XML

Annual minimum lease payments under the non-cancelable operating leases (Details) (USD $)	Mar. 31, 2015
Annual minimum lease payments Details:
Future minimum lease payments 2015	$ 138,246
Future minimum lease payments 2016	120,204
Future minimum lease payments 2017	52,996
Future minimum lease payments 2018	15,360
Total payments	$ 326,806

XML

Fair Value Measurements (Details) (USD $)	Fair Value Measurements Using Unadjusted Quoted Market Prices (Level 1) Equity Securities	Fair Value Measurements Using Quoted Prices for Identical or Similar Assets in Active Markets (Level 2) Other Investment	Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Long-Term Equity Funding Agreements
Balance. at Dec. 31, 2013	$ 21,320	$ 10,000	$ 55,943
Total gains or losses Included in earnings (or changes in net assets)	1,303	1,410	0
Purchases	18,846	0	0
Issuances	0	0	0
Sales	(35,637)	(1,150)	0
Settlements	0	0	0
Balance. at Dec. 31, 2014	5,832	10,260	55,943
Total gains or losses Included in earnings (or changes in net assets)	1,278	152	0
Purchases	1,061	0	0
Issuances	0	0	0
Sales	(1,053)	(1,150)	0
Settlements	0	0	0
Balance. at Mar. 31, 2015	$ 7,118	$ 10,412	$ 55,943

XML

Schedule of Long Term Debt (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Long Term Debt (Tables)

Schedule of Long Term Debt (Tables)

Long term debt

		March 31, 2015		December 31, 2014
Two auto loans through Compass bank, interest at 7.99% per annum, monthly principle and interest payments of $538, maturing February 2016	$	5,688	$	7,168
Auto loan through Ford Credit, interest at 6.64% per annum, monthly principle and interest payments of $467, maturing October 2015		2,747		4,087
Auto loan through Hyundai Motor Finance, interest at 2.99% per annum, monthly principle and interest payments of $878, maturing December 2018.		36,538		38,905
Total notes payable		44,973		50,160
Less:  Current maturities		(17,988)		(18,911)
	$	26,985	$	31,249

XML

Long term debt (Parentheticals) (Details) (USD $)	Mar. 31, 2015
Long term debt (Parentheticals) Details
Interest rate per annum on auto loans from Compass bank	7.99%
Monthly principal and interest payments on auto loans from Compass bank	$ 538
Interest rate per annum on auto loans through Ford Credit	6.64%
Monthly principal and interest payments on auto loans through Ford Credit	467
Interest rate per annum on auto loans through Hyundai Motor Finance	2.99%
Monthly principal and interest payments on auto loans through Hyundai Motor Finance	$ 878

XML

Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2015

Accounting Policies:

Condensed consolidated financial statements

Condensed consolidated financial statements

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  The results of operations for the periods ended March 31, 2015 and 2014 are not necessarily indicative of the operating results for the full years.

Basis of presentation

Basis of presentation

The Company’s consolidated financial statements include majority owned subsidiaries of 51% or more.    The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.  All material intercompany balances and transactions have been eliminated in consolidation.

As shown in the accompanying financial statements, the Company has a significant accumulated deficit of $3,859,810 as of March 31, 2015. The Company also continues to experience negative cash flows from operations. The Company will be required to raise additional capital to fund its operations, and will continue to attempt to raise capital resources from both related and unrelated parties until such time as the Company is able to generate revenues sufficient to maintain itself as a viable entity. These factors have raised substantial doubt about the Company's ability to continue as a going concern. There can be no assurances that the Company will be able to raise additional capital or achieve profitability. However, the Company has 14.3 million warrants outstanding in which the Company can reset the exercise price substantially below the current market price, see Note 9.   These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company raised approximately $99,855 from partial warrant redemptions from February 9, 2015 through March 31, 2015, see Note 9.  In addition, from April 1, 2015 through April 22, the Company raised approximately $79,738 from the exercise of warrants into common stock.  The Company estimates it has adequate cash reserves to support six to eighteen months of operation.  Management's plans include increasing revenues through acquisition, investment, and organic growth.  This is to be funded by raising additional capital through the sale of equity securities and debt.

Concentrations of cash

Concentrations of cash

The Company maintains its cash and cash equivalents in bank deposit accounts which at times may exceed federally insured limits.  The Company has not experienced any losses in such accounts nor does the Company believe it is exposed to any significant credit risk on cash and cash equivalents.  

Cash and cash equivalents

Cash and cash equivalents

The Company considers all short-term debt securities purchased with a maturity of three months or less to be cash equivalents. The Company had no short-term debt securities as of March 31, 2015 and 2014.

Accounts receivable

Accounts receivable

Customer accounts receivable are classified as current assets and are carried at original invoice amounts less an estimate for doubtful receivables based on a review of all outstanding amounts on a monthly basis.  The estimate of allowance for doubtful accounts is based on the Company's bad debt experience, market conditions, collateral available, and aging of accounts receivable, among other factors. If the financial condition of the Company's customers deteriorates resulting in the customer's inability to pay the Company's receivables as they come due, additional allowances for doubtful accounts will be required. At March 31, 2015 and 2014, the Company has recorded an allowance in the amount of $8,700 and $0, respectively.

Investment in unconsolidated entity

Investment in unconsolidated entity

Prior to acquiring a controlling interest in WCI on January 1, 2014, Mentor accounted for the investment in WCI using the equity method based on the ownership interest and the Company’s limited ability to exercise significant influence at December 31, 2013.  Accordingly, the investment was initially recorded at cost with adjustments to the carrying amount of the investment to recognize our share of the earnings or losses of the investee each reporting period.  Mentor ceased to recognize losses when our investment basis was zero.  At December 31, 2013, the WCI investment was $0.  On January 1, 2014, the Company purchased an additional 1% interest in WCI for a 51% interest, see Note 16.  

Convertible note receivable

Convertible note receivable

The 5% convertible note receivable from Electrum Capital Partners, LLC is recorded at the loan amount of $100,000 plus accrued interest of $5,116 and $4,942 at March 31, 2015 and December 31, 2014.  

Long term investments

Long term investments

The Company’s investments in entities where it is a minority owner and does not have the ability to exercise significant influence are recorded at fair value if readily determinable.  If the fair market value is not readily determinable, the investment is recorded under the cost-method. Under this method, the Company’s share of the earnings or losses of such investee company is not included in the Company’s financial statements. The Company reviews the carrying value of its long term investments for impairment each reporting period.

Investment in account receivable, net of discount

Investment in account receivable, net of discount

The Company invested in an account receivable and promissory note on July 8, 2014 which was due on or before January 15, 2015.  The note was paid and extinguished in March 2015.  The investment was recorded at face value with an offsetting discount at the time purchased.  The discount was amortized to interest income over the term of the note.

Property, equipment and machinery

Property, equipment and machinery

Property, equipment and machinery are recorded at cost.  Depreciation is computed on the straight-line and declining balance methods over the estimated useful lives of various classes of property ranging from 3 to 7 years.

Software development costs relate to development of MCB’s website and cannabis directory.  Software research and development costs are expensed as incurred.  Software development costs are subject to capitalization beginning when a product’s technological feasibility has been established and ending when a product is available for general release.  The Company capitalized website software costs incurred during period from inception (January 27, 2014) through October 31, 2014.  Upon the launch of the website and directory in October 2014, MCB began amortizing these costs on a straight line basis over 2 years.  

Expenditures for renewals and betterments are capitalized and maintenance and repairs are charged to expense.  Upon retirement or sale, the cost of assets disposed and the accumulated depreciation is removed from the accounts.  The resulting gain or loss is credited or charged to income.

Goodwill

Goodwill

Goodwill of $1,324,142 was derived from consolidating WCI effective January 1, 2014, see Note 16. The remaining $102,040 of goodwill relates to the 1999 acquisition of a 50% interest in WCI.  The Company accounts for its Goodwill in accordance with FASB Accounting Standards Codification 350, Intangibles – Goodwill and Other, which requires the Company to test goodwill for impairment annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable, rather than amortize. Goodwill impairment tests consist of a comparison of each reporting unit’s fair value with its carrying value. Impairment exists when the carrying amount of goodwill exceeds the implied fair value for each reporting unit. To estimate the fair value, management used valuation techniques which included the discounted value of estimated future cash flows. The evaluation of impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and are subject to change as future events and circumstances change. Actual results may differ from assumed and estimated amounts. Management determined that no impairment write-downs were required as of December 31, 2014.  There have been no changes in circumstances that would indicate an impairment at March 31, 2015.

Revenue recognition

Revenue recognition

The Company recognizes revenue in accordance with ASC 605 “Revenue Recognition”. The Company records revenue under each contract once persuasive evidence of an agreement exists, delivery has occurred or services have been rendered, the fee is fixed or determinable and collectability is reasonably assured.

Basic and diluted income (loss) per common share

Basic and diluted income (loss) per common share

Basic net income (loss) per common share (EPS) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS adjusts basic net income (loss) per common share, computed using the treasury stock method, for the effects of potentially dilutive common shares, if the effect is not antidilutive.   In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock warrants. Diluted EPS excludes all dilutive potential shares if their effect is antidilutive. Outstanding warrants that had no effect on the computation of dilutive weighted average number of shares outstanding as their effect would be antidilutive were approximately 15,198,000 and 15,210,000 as of March 31, 2015 and 2014, respectively.  There were 4,500 potentially dilutive shares outstanding at March 31, 2015 and 2014, respectively.

Income taxes

Income taxes

We utilize the asset and liability method of accounting for income taxes.  Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse.  A valuation is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

Generally accepted accounting principles provide accounting and disclosure guidance about positions taken by an organization in its tax returns that might be uncertain. Management considers the likelihood of changes by taxing authorities in its filed income tax returns and recognizes a liability for or discloses potential changes that management believes are more likely than not to occur upon examination by tax authorities.  

Management has not identified any uncertain tax positions in filed income tax returns that require recognition or disclosure in the accompanying financial statements.  The Company’s income tax returns for the past three years are subject to examination by tax authorities, and may change upon examination. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in interest expense.

Advertising and promotion

Advertising and promotion

The Company expenses advertising and promotion costs as incurred.  Advertising and promotion costs were $27,145 and $8,075 for the three months ended March 31, 2015 and 2014, respectively.

Use of estimates

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures.  Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from these estimates.

Fair value measurements

Fair value measurements

The Fair Value Measurements and Disclosure Topic defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal, or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  The valuation techniques maximize the use of observable inputs and minimize the use of unobservable inputs.

The Fair Value Measurements and Disclosure Topic establish a fair value hierarchy, which prioritizes the valuation inputs into three broad levels.  These three general valuation techniques that may be used to measure fair value are as follows:  Market approach (Level 1) – which uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.  Prices may be indicated by pricing guides, sale transactions, market trades, or other sources.  Cost approach (Level 2) – which is based on the amount that currently would be required to replace the service capacity of an asset (replacement cost); and the Income approach (Level 3) – which uses valuation techniques to convert future amounts to a single present amount based on current market expectations about the future amounts (including present value techniques, and option-pricing models).  Net present value is an income approach where a stream of expected cash flows is discounted at an appropriate market interest rate.

The carrying amounts of cash, accounts receivable, prepaid expenses and other current assets, accounts payable, customer deposits and other accrued liabilities approximate their fair value due to the short-term nature of these instruments.

The fair value of the note receivable is based on the net present value of calculated interest and principle payments.  The carrying value approximates fair value as interest rates charged are comparable to market rates for similar notes.

The fair value of long-term notes payable is based on the net present value of calculated interest and principle payments.  The carrying value of long-term debt approximates fair value due to the fact that the interest rate on the debt is based on market rates.

Recent Accounting Standards

Recent Accounting Standards

The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

XML

Summary of Common Stock Warrants - E, F, G, H (Details)	Series E $ 1.00 exercise price	Series F $ 3.00 exercise price	Series G $ 0.65 exercise price	Series H $ 7.00 exercise price	E,F,G,H Total Warrants
Outstanding. at Dec. 31, 2013	107,931	369,037	88,579	689,159	1,254,706
Issued	0	0	0	0	0
Exercised	(107,931)	(369,037)	(88,579)	0	(565,547)
Outstanding at Dec. 31, 2014	0	0	0	689,159	689,159
Issued	0	0	0	0	0
Exercised	0	0	0	0	0
Shares issued in 2014 as a result of cashless exercise at Mar. 31, 2015	73,388	210,870	70,152	0	354,410
Outstanding. at Mar. 31, 2015	0	0	0	689,159	689,159

XML

Investment in account receivable during the period (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Investment in account receivable discount amortization:
Discount amortization included in interest income	$ 2,250	$ 0

XML

Schedule of operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes

Schedule of operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

		Three months ended March 31
		2015		2014
Operating income (loss)	$	(183,317)	$	(90,469)
Gain recognized on purchase of majority interest in WCI		-		1,250,000
Interest income		2,389		-
Interest expense		(4,000)		(4,490)
Gain on investments		1,339		1,377
Other income		-		75
Income before income taxes	$	(183,589)	$	1,156,493

XML

Funding agreement (Details) (USD $)	Mar. 31, 2015
Funding agreement Details
Funding agreement with MCB to purchase up to	51.00%
MCB was to receive in funding	$ 200,000
Allocation of funding to MCB is discretionary and could be reduced to	$ 100,000

XML

Subsequent events (Details) (USD $)	Apr. 27, 2015	Apr. 20, 2015	Apr. 13, 2015	Apr. 10, 2015
Subsequent events Details
Company received payment for the face amount of the investment in account receivable				$ 117,000
Company received payment for the face amount of the investment in account receivable in exchange for shares of Mentor stock				757,059
Acquired 100% of a Georgia sole proprietorship, dba Investor Webcast (CAST) valued		469,611
Acquired 100% of a Georgia sole proprietorship, dba Investor Webcast (CAST) exchange for series B convertible preferred shares of Mentor		4,696
Mentor notified MCB that the amount of funding provided by Mentor would be reduced to			100,000
Note receivable from MCB	$ 74,000
Note receivable bears interest	6.00%

XML

Purchase price to be allocated (Details) (USD $)	Mar. 31, 2015
Purchase price to be allocated Details
Cash to acquire additional 1% equity interest in WCI	$ 25,000
Fair value of 50% interest (a)	1,250,000
Investment under equity method	0
Total purchase price to be allocated	$ 1,275,000

XML

Common Stock Warrants (Details) (USD $)	Jun. 18, 2014	Apr. 01, 2013	Dec. 31, 2012	Aug. 21, 2012	Mar. 21, 2012
Exercise Prices Details:
Series A		$ 0.01	$ 1.00	$ 0.09	$ 0.09
Series B	$ 0.11	$ 0.11	$ 3.00	$ 0.11	$ 3.00
Series C		$ 0.09	$ 0.65	$ 0.65	$ 0.65
Series D	$ 1.60	$ 7.00	$ 7.00	$ 7.00	$ 7.00

XML

Acquisition of interest in Bhang Chocolate Company, Inc. and suit seeking rescission

3 Months Ended

Mar. 31, 2015

Acquisition of interest in Bhang Chocolate Company, Inc. and suit seeking rescission:

Acquisition of interest in Bhang Chocolate Company, Inc. and suit seeking rescission

Note 4 - Acquisition of interest in Bhang Chocolate Company, Inc. and suit seeking rescission

On January 17, 2014, the Company transitioned out of its cancer related trading dormancy by announcing its first cannabis sector letter of intent amidst significantly increased share volume and price.  The Company entered into a co-operative funding agreement with Bhang Chocolate Company, Inc. on February 28, 2014, that provided for the purchase from owners of a 60% ownership in Bhang.   Mentor anticipated funding the co-operative funding agreement through unrelated debt funding.  Bhang owners were to receive $9,000,000 in consideration in the first 90 days.  During the first 90 days, $1,500,000 was provided to Bhang owners in cash from proceeds of warrant exercises.  The lending equity group was unable to fund the loan they announced.  Mentor tendered the remaining $7,500,000 to the Bhang owners in freely trading shares of Mentor Common Stock per the terms of the co-operative agreement.  The Bhang owners refused Mentor’s tender of stock.

On June 24, 2014, Bhang owners unilaterally announced that Bhang was no longer doing any business with Mentor.  Bhang failed to provide Mentor with Bhang share certificates evidencing the Bhang shares purchased by Mentor or provide other promised consideration to Mentor, effectively repudiating the co-operative agreement by their actions.  In addition, Bhang owners have declined to return any of the $1,500,000 invested by Mentor.  On August 11, 2014, Mentor filed suit against Bhang and its owners, in the United States District Court for the Northern District of California for rescission seeking return of the $1,500,000 investment the Company made in Bhang.  The parties have been ordered to undergo arbitration, which was initiated in January 2015.  The suit in the District Court has been stayed pending the outcome of arbitration, see Note 17.

XML

Purchase price allocation at 51% of WCI assets and liabilities (Details) (USD $)	Mar. 31, 2015
Purchase price allocation at 51% of WCI assets and liabilities
Current assets	$ 327,238
Property and equipment	51,239
Other assets	816,952
Current liabilities	(112,810)
Long-term debt	(1,178,977)
Net deficit	(96,358)
Mentor equity rate	51.00%
Mentor portion of liabilities in excess of assets	(49,143)
Goodwill	1,324,143
Net assets acquired	$ 1,275,000

XML

Property and equipment (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Property and equipment is comprised of the following:
Computers	$ 15,187	$ 15,187
Furniture and fixtures	20,712	19,491
Machinery and vehicles	179,375	179,375
Capitalized software	25,007	25,007
Property and equipment	240,281	239,060
Accumulated depreciation and amortization	(164,978)	(157,484)
Property and equipment, net	$ 75,303	$ 81,576

XML

Schedule of Hierarchy of Assets (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Hierarchy of Assets (Tables):

Schedule of Hierarchy of Assets (Tables)

The hierarchy of Level 1, Level 2 and Level 3 Assets are listed as following:

	Fair Value Measurements Using Unadjusted Quoted Market Prices (Level 1)	Fair Value Measurements Using Quoted Prices for Identical or Similar Assets in Active Markets (Level 2)	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Equity Securities	Other investment	Long-Term Equity Funding Agreements
Balance at December 31, 2013	21,320	10,000	55,943
Total gains or losses
Included in earnings (or changes in net assets)	1,303	1,410	-
Purchases, issuances, sales, and settlements
Purchases	18,846	-	-
Issuances	-	-	-
Sales	(35,637)	(1,150)	-
Settlements	-	-
Balance at December 31, 2014	5,832	10,260	55,943

	Fair Value	Fair Value	Fair Value
	Measurements	Measurements	Measurements
	Using	Using	Using
	Unadjusted Quoted Market Prices	Quoted Prices for Identical or Similar Assets in Active Markets	Significant Unobservable  nputs
	(Level 1)	(Level 2)	(Level 3)
	Equity Securities	Other investment	Long-Term Equity Funding Agreements
Total gains or losses
Included in earnings (or changes in net assets)	1,278	152	-
Purchases, issuances, sales, and settlements
Purchases	1,061	-	-
Issuances	-	-	-
Sales	(1,053)	-	-
Settlements	-	-
Balance at March 31, 2015	$                  7,118	$                 10,412	$                55,943

XML

Schedule of Property and Equipment (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Property and Equipment:

Schedule of Property and Equipment

Property and equipment is comprised of the following at March 31, 2015 and December 31, 2014:

		March 31, 2015		December 31, 2014
Computers	$	15,187	$	15,187
Furniture and fixtures		20,712		19,491
Machinery and vehicles		179,375		179,375
Capitalized software		25,007		25,007
		240,281		239,060
Accumulated depreciation and amortization		(164,978)		(157,484)
Net Property and equipment	$	75,303	$	81,576

XML

Long term debt (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Long term debt Details
Two auto loans through Compass bank, interest at 7.99% per annum, monthly principle and interest payments of $538, maturing February 2016	$ 5,688	$ 7,168
Auto loan through Ford Credit, interest at 6.64% per annum, monthly principle and interest payments of $467, maturing October 2015	2,747	4,087
Auto loan through Hyundai Motor Finance, interest at 2.99% per annum, monthly principle and interest payments of $878, maturing December 2018.	36,538	38,905
Total notes payable	44,973	50,160
Less: Current maturities	(17,988)	(18,911)
Long term debt, net of current portion	$ 26,985	$ 31,249

XML

Property and equipment During the period (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Property and equipment During the period
Depreciation and amortization	$ 7,494	$ 9,459

XML

Schedule of Stock option activity (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Stock option activity (Tables):

Schedule of Stock option activity

Exercise prices at December 31, 2012 and subsequent lower prices for the A, B, C and D warrants are as follow:

	Series A	Series B	Series C	Series D
December 31, 2012	$     1.00	$     3.00	$     0.65	$     7.00
March 21, 2012	$     0.09	$     3.00	$     0.65	$     7.00
August 21, 2012	$     0.09	$     0.11	$     0.65	$     7.00
April 1, 2013	$     0.01	$     0.11	$     0.09	$     7.00
June 18, 2014	$           -	$     0.11	$           -	$     1.60

Schedule of Assumptions used to value the options granted and warrants issued using the Black-Scholes option pricing model:

The following table provides the assumptions used to value the options granted and warrants issued using the Black-Scholes option pricing model:

	Series E	Series F
	and G	and H
Stock price volatility	111.60%	111.60%
Risk-free rate of return	4.26%	4.26%
Annual dividend yield	0.00%	0.00%
Expected life (in years)	0.5	3.0

XML

Schedule of summary of common stock warrants (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of summary of common stock warrants (Tables)

Schedule of summary of common stock warrants (Tables)

The following table summarizes common stock warrants as of each period:

	Series A	Series B	Series C	Series D	A,B,C,D Total Warrants
Outstanding at December 31, 2013	1,188,909	5,332,981	128,180	15,312,627	21,962,697
Issued	-	-	-	-	-
Exercised	(1,188,909)	(5,328,481)	(128,180)	(807,861)	(7,453,431)
Outstanding at December 31, 2014	-	4,500	-	14,504,766	14,509,266
Issued	-	-	-	-	-
Exercised	-	-	-	(226,740)	(226,740)
Outstanding at March 31, 2015	-	4,500	-	14,278,026	14,282,526

Series E, F, G and H warrants were issued for investment banking and advisory services during 2009.  The following table summarizes E, F, G and H warrants as of each period:

	Series E    $1.00 exercise   price	Series F $3.00 exercise price	Series G  $0.65 exercise price	Series H  $7.00 exercise price	E,F,G,H Total Warrants
Outstanding at December 31, 2013	107,931	369,037	88,579	689,159	1,254,706
Issued	-	-	-	-	-
Exercised	(107,931)	(369,037)	(88,579)	-	(565,547)
Outstanding at December 31, 2014	-	-	-	689,159	689,159
Issued	-	-	-	-	-
Exercised	-	-	-	-	-
Outstanding at March 31, 2015	-	-	-	689,159	689,159
Shares issued in 2014 as a result of cashless exercise	73,388	210,870	70,152	-	354,410

XML

Prepaid expenses and other assets

3 Months Ended

Mar. 31, 2015

Prepaid expenses and other assets:

Prepaid expenses and other assets

Note 3 – Prepaid expenses and other assets

Prepaid expenses and other assets consist of the following:

		March 31, 2015		December 31, 2014
Prepaid advertising costs	$	3,637	$	27,708
Prepaid legal fees		9,145		9,145
Other prepaid costs		28,218		28,218
	$	41,000	$	55,655

XML

Schedule of remaining annual minimum lease payments under the non-cancelable operating leases (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of remaining annual minimum lease payments under the non-cancelable operating leases (Tables):

Schedule of remaining annual minimum lease payments under the non-cancelable operating leases

The approximate remaining annual minimum lease payments under the non-cancelable operating leases existing as of December 31, 2014 with original or remaining terms over one year were as follows:

Years ending		Rental
December 31,		expense
2015	$	138,246
2016		120,204
2017		52,996
2018		15,360
	$	326,806

XML

Acquisition of interest in Bhang Chocolate Company, Inc. and suit seeking rescission (Details) (USD $)	Aug. 11, 2014	Jun. 24, 2014	Jan. 17, 2014
Acquisition of interest in Bhang Chocolate Company, Inc. and suit seeking rescission Details
Provided for the purchase from owners of a ownership in Bhang on February 28, 2014 (in Percent)			60.00%
Bhang owners were to receive in consideration in the first 90 days			$ 9,000,000
Provided to Bhang owners in cash from proceeds of warrant exercises			1,500,000
Tendered the remaining to the Bhang owners in freely trading shares of Mentor Common Stock per the terms of the co-operative agreement			7,500,000
Bhang owners have declined to return any of invested amount		1,500,000
Filed suit against Bhang and its owners for rescission seeking return of the investment	$ 1,500,000

XML

CAPITAL STOCK TRANSACTIONS (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Aug. 08, 2014
Shares Authorized:
Common stock authorized shares	400,000,000	400,000,000
Common stock shares no par value	$ 0.00	$ 0.00
Company announced a stock repurchase plan which allowed for a total of	12.50%	12.50%
Company announced that it was initiating the repurchase of approximately			2.00%
Shares have been repurchased and retired	21,848	21,848

XML

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 348,794	$ 326,228
Accounts receivable, net	301,785	300,947
Prepaid expenses and other current assets	41,000	55,655
Investment in account receivable, net of discount	0	114,750
Investments in securities, at fair value	7,118	5,832
Employee advances	1,300	2,500
Total current assets	699,997	805,912
Property and equipment
Property and equipment	240,281	239,060
Accumulated depreciation and amortization	(164,978)	(157,484)
Property and equipment, net	75,303	81,576
Other assets
Receivable - Bhang Corporation and shareholders	1,500,000	1,500,000
Deposits	9,575	9,575
Convertible note receivable	105,116	104,942
Long term investments	66,355	66,203
Goodwill	1,426,182	1,426,182
Total other assets	3,107,228	3,106,902
Total assets	3,882,528	3,994,390
Current liabilities
Accounts payable	54,282	65,585
Accrued expenses	147,673	166,423
Line of credit	60,000	60,000
Current portion of long term debt	17,988	18,911
Total current liabilities	279,943	310,919
Long-term liabilities
Accrued salary, retirement and benefits - related party	305,154	272,982
Long term debt, net of current portion	26,985	31,249
Total long-term liabilities	332,139	304,232
Commitments and Contingencies
Shareholders' equity
Preferred stock, no par value, 100,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, no par value, 400,000,000 shares authorized; 14,709,951 and 14,483,215 shares issued and outstanding at March 31, 2015 and December 31, 2014	7,101,763	7,001,908
Additional paid in capital	234,731	234,731
Accumulated deficit	(3,859,810)	(3,652,101)
Non-controlling interest	(206,238)	(205,298)
Total shareholders' equity	3,270,446	3,379,240
Total liabilities and shareholders' equity	$ 3,882,528	$ 3,994,390

XML

Convertible note receivable (Details) (USD $)	Mar. 31, 2015
Convertible notes receivable Details
Convertible note receivable	$ 100,000
Accrued interest	4,942
Note bears interest rate per annum	5.00%
Increase in interest rate	10.00%
Payments of principal and interest in the amount	$ 2,289.83

XML

Nature of operations

3 Months Ended

Mar. 31, 2015

Nature of operations

Nature of operations

Note 1 - Nature of operations

History (1985 – 2008)

Mentor Capital, Inc. (“Mentor” or “the Company”) was founded as an investment partnership by the current CEO in 1985 and incorporated July 29, 1994, under the laws of the State of California. On September 12, 1996, the Company’s offering statement was qualified pursuant to Regulation A of the Securities Act, and the Company began to trade its shares publicly. On August 21, 1998, the Company filed voluntary reorganization with the bankruptcy court and, on January 11, 2000, the Company emerged from Chapter 11. The Company contracted to provide financial assistance and investment into small businesses following its reorganization.

Current Business (2008 - 2013)

Since the August 2008, name change back to Mentor Capital, Inc., the Company’s common stock has traded publicly under the trading symbol OTC Markets: MNTR.

In 2009, the Company began focusing its investing activities in leading edge cancer companies. In 2012, in response to government limitations on reimbursement for highly technical and expensive cancer treatments and a resulting business decline in the cancer development sector, the Company decided to exit that space.  In the summer of 2013 the Company was asked to consider investing in a cancer related project with a medical marijuana focus.   On August 29, 2013, the Company made a decision to divest of its cancer assets and focus all future investments in the cannabis and medical marijuana sector.   

Effective January 1, 2014, Mentor purchased an additional 1% interest in Waste Consolidators, Inc. (“WCI”) for $25,000 which resulted in a 51% ownership in WCI.  At December 31, 2013, Mentor’s investment in WCI was recorded under the equity method.  In accordance with Accounting Standard Codification 810-10, Consolidation – Overall, on January 1, 2014 Mentor remeasured its previously held equity interest at the acquisition-date fair value and recognized the resulting gain on investment in subsidiary, see Note 16.  WCI was incorporated in Colorado in 1999 and operates in Arizona.  It is a legacy investment which was acquired prior to the Company’s current focus on the cannabis sector and is included in the consolidated financial statements for the year ended December 31, 2014.

On February 18, 2014, the Company signed an agreement to purchase a 51% interest in MicroCannaBiz, LLC (“MCB”), for $200,000, see Note 11.  MCB is a Limited Liability Company organized in Florida in January 2014 which began operations in June 2014.  MCB provides cannabis and marijuana related private companies, investors and microcap issuers with information resources including client company specific publications, directories, and continuing education courses.   MCB operations are included in the consolidated financial statements for the year ended December 31, 2014.  

On February 28, 2014, the Company acquired a 60% ownership in Bhang Chocolate Company, Inc. (“Bhang”), see Note 4 regarding the purchase and subsequent Mentor lawsuit seeking rescission of the agreement.  Amounts invested in Bhang are reported as Receivable from Bhang Chocolate Company shareholders in the consolidated balance sheet at December 31, 2014 and March 31, 2015.

XML

Accrued salary, accrued retirement and related party incentive fee - Outstanding liability to Chief Executive Officer (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Outstanding liability to Chief Executive Officer
Accrued salaries and benefits	$ 721,987	$ 716,055
Accrued incentive fee and bonus	190,581	190,581
Accrued retirement and other benefits	441,917	439,751
Offset by shareholder advance	(1,049,331)	(1,073,405)
Total Outstanding liability to Chief Executive Officer	$ 305,154	$ 272,982

XML

Schedule of Purchase of additional equity in WCI (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Purchase of additional equity in WCI (Tables):

Schedule of Purchase of additional equity in WCI (Tables)

In accordance with Accounting Standard Codification 810-10, Consolidation – Overall, Mentor remeasured its previously held equity interest at the acquisition-date fair value and recognized the resulting gain of $1,250,964 on investment in subsidiary which is included in other income and expense in the consolidated statement of operations.

Cash to acquire additional 1% equity interest in WCI	$	25,000
Fair value of 50% interest (a)		1,250,000
Investment under equity method		-
Total purchase price to be allocated	$	1,275,000

(a) Estimated fair value of Mentor’s previously-held equity interest in WCI is valued at 1.25 times WCI’s projected 2014 revenue.

Purchase price allocation at 51% of WCI assets and liabilities:

WCI assets and liabilities:
Current assets	$	327,238
Property and equipment		51,239
Other assets		816,952
Current liabilities		(112,810)
Long-term debt		(1,178,977)
Net deficit		(96,358)
Mentor equity rate		51%
Mentor portion of liabilities in excess of assets		(49,143)
Goodwill		1,324,143
Net assets acquired	$	$1,275,000

XML

Segment Information (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cannabis and Medical Marijuana Segment
Net sales	$ 0	$ 0
Income (loss) from operations	0	(21,551)
Total assets	1,626,740	1,600,927
Interest expense	0	0
Depreciation and amortization	0	0
Legacy Investments
Net sales	573,850	490,808
Income (loss) from operations	55,462	68,035
Total assets	1,114,834	1,122,564
Interest expense	4,774	4,093
Depreciation and amortization	6,810	6,091
Corporate and Eliminations
Net sales	0	0
Income (loss) from operations	(245,316)	(136,953)
Total assets	1,140,954	1,270,899
Interest expense	(774)	397
Depreciation and amortization	683	3,369
Consolidated
Net sales	573,850	490,808
Income (loss) from operations	(183,317)	(90,469)
Total assets	3,882,528	3,994,390
Interest expense	4,000	4,490
Depreciation and amortization	$ 7,493	$ 9,460

XML

Commitment and Contingencies

3 Months Ended

Mar. 31, 2015

Commitment and Contingencies:

Commitments and Contingencies Disclosure

Note 17 – Commitments and contingencies

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with FASB ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines than an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of March 31, 2015, the Company is not aware of any contingent liabilities that should be reflected in the accompanying financial statements.

Mentor lawsuit seeking rescission of co-operative funding agreement with Bhang

On August 11, 2014, Mentor filed suit against Bhang and its owners, in the United States District Court for the Northern District of California for rescission of the February 28, 2014 co-operative funding agreement with Bhang, seeking return of the $1,500,000 investment the Company made in Bhang.  This was in response to the June 24, 2014, unilateral announcement by Bhang that they were terminating all details of their relationship with Mentor, leaving Mentor with nothing, but declining to return any of the $1,500,000 paid to Bhang and owners by Mentor during the preceding and only four months of interaction. As directed by the court, arbitration has been initiated with the American Arbitration Association and the first administrative conference occurred in March 2015.  The Company intends to continue to vigorously pursuing return of its $1,500,000.  See Note 4.

In March 2015, Bhang and its owners filed a counterclaim against Mentor in the arbitration action.  Bhang contends it has suffered losses and should be able to keep the $1,500,000 they received from Mentor.  The final outcome of the arbitration is not known at this time.  The Company believes the counterclaim is without merit and plans to vigorously defend itself against all claims.

In March 2014, the Company paid $621,250, which represented 1.75% of a prospective loan amount, in refundable fees paid for credit default insurance to a third party as required by the lender on an international loan facility.  The lender was unable to fund the loan and a cooperative exit from the loan commitment was agreed to by the parties on June 12, 2014.  The lender has released the requirement for credit default insurance and the insurance company has agreed to return the fee, however the refund has not yet been received.  On September 5, 2014, the Company filed suit in San Mateo County Superior Court against Wm. E. Fielding and Associates, Inc., the name of the account holder to whom the $621,250 was wired, for conversion and fraud seeking return of the $621,250 in credit insurance premiums that had been paid, had been promised to be returned, and which were not returned.  The defendant defaulted and the Company intends to prove its damages, take a judgment, and pursue collecting its damages from the defendant.  The Company plans to continue to vigorously pursue return of its $621,250.  The $621,250 in fees was expensed as loan costs in June 2014, pending the outcome of the suit.

XML

Schedule of Segments (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Segments (Tables)

Schedule of Segment Reporting Information, by Segment

The Company also has certain small cancer related legacy investments and an $117,000 investment in note receivable from a non-affiliated party that is included in Corporate below.  

		Cannabis and Medical Marijuana Segment		Legacy Investment		Corporate and Eliminations		Consolidated
Three months ended March 2015
Net sales	$	-	$	573 850	$	-	$	573,850
Income (loss) from operations		-		55 462		(245,316)		(183,317)
Total assets		1,626,740		1,114,834		1,140,954		3,882,528
Interest expense		-		4,774		(774)		4,000
Depreciation and amortization		-		6,810		683		7,493
Three months ended March 2014
Net sales	$	-	$	490,808	$	-	$	490,808
Income (loss) from operations		(21,551)		68,035		(136,953)		(90,469)
Total assets		1,600,927		1,122,564		1,270,899		3,994,390
Interest expense		-		4,093		397		4,490
Depreciation and amortization		-		6,091		3,369		9,460

XML

Subsequent events

3 Months Ended

Mar. 31, 2015

Subsequent events:

Subsequent events

Note 19 - Subsequent events

On April 10, 2015, the Company entered into an exchange agreement whereby the Company will receive an investment in installment accounts receivable of $117,000 per year for 11 years totaling $1,287,000 in exchange for 757,059 shares of Mentor stock which were obtained through exercise of series D warrants at $1.60 per share.   

On April 20, 2015, the Company acquired 100% of a Georgia sole proprietorship, dba Investor Webcast (CAST) valued at $469,611 in exchange for 4,696 to-be-created series B convertible preferred shares of Mentor.  CAST provides cannabis related private companies, investors and microcap issuers with the best possible investor information through webcasts, conferences, email and an evolving mix of media products, investment publications, industry financial research, and by other means.  After one year, the to-be-created series B convertible preferred shares may be converted, in steps or in whole, into Mentor common shares.  The to-be-created series B convertible preferred shares will convert to Common based on the following conversion formula:  ((3.3 times CAST recurring revenue) + (20 times CAST after tax profit) divided by 2) plus cash minus liabilities, for the preceding four calendar quarters, as defined in the agreement.  

On April 13, 2015, Mentor notified MCB that the amount of funding provided by Mentor would be reduced to $100,000.  On April 27, 2015, Mentor notified MCB that it was exercising it’s option to convert it’s equity in MCB to a ten year note receivable for $74,000 from MCB as provided in the funding agreement.  The note receivable bears interest at 6% and will be payable in monthly installments.

XML

Summary of significant accounting policies

3 Months Ended

Mar. 31, 2015

Summary of significant accounting policies

Summary of significant accounting policies

Note 2 - Summary of significant accounting policies

Condensed consolidated financial statements

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  The results of operations for the periods ended March 31, 2015 and 2014 are not necessarily indicative of the operating results for the full years.

Basis of presentation

The Company’s consolidated financial statements include majority owned subsidiaries of 51% or more.    The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.  All material intercompany balances and transactions have been eliminated in consolidation.

As shown in the accompanying financial statements, the Company has a significant accumulated deficit of $3,859,810 as of March 31, 2015. The Company also continues to experience negative cash flows from operations. The Company will be required to raise additional capital to fund its operations, and will continue to attempt to raise capital resources from both related and unrelated parties until such time as the Company is able to generate revenues sufficient to maintain itself as a viable entity. These factors have raised substantial doubt about the Company's ability to continue as a going concern. There can be no assurances that the Company will be able to raise additional capital or achieve profitability. However, the Company has 14.3 million warrants outstanding in which the Company can reset the exercise price substantially below the current market price, see Note 9.   These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company raised approximately $99,855 from partial warrant redemptions from February 9, 2015 through March 31, 2015, see Note 9.  In addition, from April 1, 2015 through April 22, the Company raised approximately $79,738 from the exercise of warrants into common stock.  The Company estimates it has adequate cash reserves to support six to eighteen months of operation.  Management's plans include increasing revenues through acquisition, investment, and organic growth.  This is to be funded by raising additional capital through the sale of equity securities and debt.

Concentrations of cash

The Company maintains its cash and cash equivalents in bank deposit accounts which at times may exceed federally insured limits.  The Company has not experienced any losses in such accounts nor does the Company believe it is exposed to any significant credit risk on cash and cash equivalents.  

Cash and cash equivalents

The Company considers all short-term debt securities purchased with a maturity of three months or less to be cash equivalents. The Company had no short-term debt securities as of March 31, 2015 and 2014.

Accounts receivable

Customer accounts receivable are classified as current assets and are carried at original invoice amounts less an estimate for doubtful receivables based on a review of all outstanding amounts on a monthly basis.  The estimate of allowance for doubtful accounts is based on the Company's bad debt experience, market conditions, collateral available, and aging of accounts receivable, among other factors. If the financial condition of the Company's customers deteriorates resulting in the customer's inability to pay the Company's receivables as they come due, additional allowances for doubtful accounts will be required. At March 31, 2015 and 2014, the Company has recorded an allowance in the amount of $8,700 and $0, respectively.

Investment in unconsolidated entity

Prior to acquiring a controlling interest in WCI on January 1, 2014, Mentor accounted for the investment in WCI using the equity method based on the ownership interest and the Company’s limited ability to exercise significant influence at December 31, 2013.  Accordingly, the investment was initially recorded at cost with adjustments to the carrying amount of the investment to recognize our share of the earnings or losses of the investee each reporting period.  Mentor ceased to recognize losses when our investment basis was zero.  At December 31, 2013, the WCI investment was $0.  On January 1, 2014, the Company purchased an additional 1% interest in WCI for a 51% interest, see Note 16.  

Convertible note receivable

The 5% convertible note receivable from Electrum Capital Partners, LLC is recorded at the loan amount of $100,000 plus accrued interest of $5,116 and $4,942 at March 31, 2015 and December 31, 2014.  

Long term investments

The Company’s investments in entities where it is a minority owner and does not have the ability to exercise significant influence are recorded at fair value if readily determinable.  If the fair market value is not readily determinable, the investment is recorded under the cost-method. Under this method, the Company’s share of the earnings or losses of such investee company is not included in the Company’s financial statements. The Company reviews the carrying value of its long term investments for impairment each reporting period.

Investment in account receivable, net of discount

The Company invested in an account receivable and promissory note on July 8, 2014 which was due on or before January 15, 2015.  The note was paid and extinguished in March 2015.  The investment was recorded at face value with an offsetting discount at the time purchased.  The discount was amortized to interest income over the term of the note.

Property, equipment and machinery

Property, equipment and machinery are recorded at cost.  Depreciation is computed on the straight-line and declining balance methods over the estimated useful lives of various classes of property ranging from 3 to 7 years.

Software development costs relate to development of MCB’s website and cannabis directory.  Software research and development costs are expensed as incurred.  Software development costs are subject to capitalization beginning when a product’s technological feasibility has been established and ending when a product is available for general release.  The Company capitalized website software costs incurred during period from inception (January 27, 2014) through October 31, 2014.  Upon the launch of the website and directory in October 2014, MCB began amortizing these costs on a straight line basis over 2 years.  

Expenditures for renewals and betterments are capitalized and maintenance and repairs are charged to expense.  Upon retirement or sale, the cost of assets disposed and the accumulated depreciation is removed from the accounts.  The resulting gain or loss is credited or charged to income.

Goodwill

Goodwill of $1,324,142 was derived from consolidating WCI effective January 1, 2014, see Note 16. The remaining $102,040 of goodwill relates to the 1999 acquisition of a 50% interest in WCI.  The Company accounts for its Goodwill in accordance with FASB Accounting Standards Codification 350, Intangibles – Goodwill and Other, which requires the Company to test goodwill for impairment annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable, rather than amortize. Goodwill impairment tests consist of a comparison of each reporting unit’s fair value with its carrying value. Impairment exists when the carrying amount of goodwill exceeds the implied fair value for each reporting unit. To estimate the fair value, management used valuation techniques which included the discounted value of estimated future cash flows. The evaluation of impairment requires the Company to make assumptions about future cash flows over the life of the asset being evaluated. These assumptions require significant judgment and are subject to change as future events and circumstances change. Actual results may differ from assumed and estimated amounts. Management determined that no impairment write-downs were required as of December 31, 2014.  There have been no changes in circumstances that would indicate an impairment at March 31, 2015.

Revenue recognition

The Company recognizes revenue in accordance with ASC 605 “Revenue Recognition”. The Company records revenue under each contract once persuasive evidence of an agreement exists, delivery has occurred or services have been rendered, the fee is fixed or determinable and collectability is reasonably assured.

Basic and diluted income (loss) per common share

Basic net income (loss) per common share (EPS) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS adjusts basic net income (loss) per common share, computed using the treasury stock method, for the effects of potentially dilutive common shares, if the effect is not antidilutive.   In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock warrants. Diluted EPS excludes all dilutive potential shares if their effect is antidilutive. Outstanding warrants that had no effect on the computation of dilutive weighted average number of shares outstanding as their effect would be antidilutive were approximately 15,198,000 and 15,210,000 as of March 31, 2015 and 2014, respectively.  There were 4,500 potentially dilutive shares outstanding at March 31, 2015 and 2014, respectively.

Income taxes

We utilize the asset and liability method of accounting for income taxes.  Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse.  A valuation is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

Generally accepted accounting principles provide accounting and disclosure guidance about positions taken by an organization in its tax returns that might be uncertain. Management considers the likelihood of changes by taxing authorities in its filed income tax returns and recognizes a liability for or discloses potential changes that management believes are more likely than not to occur upon examination by tax authorities.  

Management has not identified any uncertain tax positions in filed income tax returns that require recognition or disclosure in the accompanying financial statements.  The Company’s income tax returns for the past three years are subject to examination by tax authorities, and may change upon examination. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in interest expense.

Advertising and promotion

The Company expenses advertising and promotion costs as incurred.  Advertising and promotion costs were $27,145 and $8,075 for the three months ended March 31, 2015 and 2014, respectively.

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures.  Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from these estimates.

Fair value measurements

The Fair Value Measurements and Disclosure Topic defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal, or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  The valuation techniques maximize the use of observable inputs and minimize the use of unobservable inputs.

The Fair Value Measurements and Disclosure Topic establish a fair value hierarchy, which prioritizes the valuation inputs into three broad levels.  These three general valuation techniques that may be used to measure fair value are as follows:  Market approach (Level 1) – which uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.  Prices may be indicated by pricing guides, sale transactions, market trades, or other sources.  Cost approach (Level 2) – which is based on the amount that currently would be required to replace the service capacity of an asset (replacement cost); and the Income approach (Level 3) – which uses valuation techniques to convert future amounts to a single present amount based on current market expectations about the future amounts (including present value techniques, and option-pricing models).  Net present value is an income approach where a stream of expected cash flows is discounted at an appropriate market interest rate.

The carrying amounts of cash, accounts receivable, prepaid expenses and other current assets, accounts payable, customer deposits and other accrued liabilities approximate their fair value due to the short-term nature of these instruments.

The fair value of the note receivable is based on the net present value of calculated interest and principle payments.  The carrying value approximates fair value as interest rates charged are comparable to market rates for similar notes.

The fair value of long-term notes payable is based on the net present value of calculated interest and principle payments.  The carrying value of long-term debt approximates fair value due to the fact that the interest rate on the debt is based on market rates.  

Recent Accounting Standards

The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

XML

Condensed Consolidated Balance Sheets Parentheticals (USD $)	Mar. 31, 2015	Dec. 31, 2014
Parentheticals
Preferred stock,no par value	$ 0	$ 0
Preferred stock, shares authorized	100,000,000	100,000,000
Common stock,no par value	$ 0	$ 0
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	14,709,951	14,483,215
Common stock, shares outstanding	14,709,951	14,483,215

XML

Stockholders' equity

3 Months Ended

Mar. 31, 2015

Stockholders' equity:

Stockholders' equity

Note 12 - Stockholders’ equity

Common Stock

The Company has a total of 400,000,000 shares of Common Stock, no par value, authorized at March 31, 2015 and December 31, 2014. The holders of Common Stock are entitled to one vote per share on all matters submitted to a vote of the stockholders and may accumulate their votes for the election of directors. During 2007, the Company effected a 1,000 to 1 reverse stock split on its outstanding common stock, under the authority of the Plan, and subsequent to receiving 84% shareholder approval and Board of Directors approval. During September 2008, the Company announced a stock repurchase plan which allowed for a total of 12.5% of the Company’s shares outstanding at that time to be repurchased during future periods. All shares under the 2008 repurchase plan were repurchased as of January 2014.    

On August 8, 2014, the Company announced that it was initiating the repurchase of approximately 2% of the Company’s   shares outstanding at that time.  As of March 31, 2015 and December 31, 2014, 21,848 shares have been repurchased and retired.

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 29, 2015
Document and Entity Information:
Entity Registrant Name	Mentor Capital, Inc.
Entity Trading Symbol	MNTR
Document Type	10-Q
Document Period End Date	Mar. 31, 2015
Amendment Flag	false
Entity Central Index Key	0001599117
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		15,668,358
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

XML

Lease commitments

3 Months Ended

Mar. 31, 2015

Lease commitments:

Lease commitments

Note 13 - Lease commitments

Operating Leases

Mentor currently rents approximately 2,000 square feet of office space on a month-to-month basis in Ramona, California in San Diego County. Rent expense for the three months ended March 31, 2015 and 2014 were $4,100 and $8,092, respectively.   

WCI rents approximately 3,000 of office and warehouse space in Tempte, Arizona under an operating lease expiring in January 2017.  Rent expense for the three months ended March 31, 2015 and 2014 was $6,540 and $6,633, respectively.    

WCI leases vehicles under a master fleet management agreement with initial terms of 4 years expiring through September 2018.  Vehicle lease expense of $21,400 and $21,811 is included in cost of sales in the consolidated income statement for the three months ended March 31, 2015 and 2014.  

The approximate remaining annual minimum lease payments under the non-cancelable operating leases existing as of December 31, 2014 with original or remaining terms over one year were as follows:

Years ending		Rental
December 31,		expense
2015	$	138,246
2016		120,204
2017		52,996
2018		15,360
	$	326,806

XML

Condensed Consolidated Income Statements (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenue
Service fees	$ 573,850	$ 490,808
Publication revenue	0	0
Other revenue	0	0
Total revenue	573,850	490,808
Cost of sales	335,913	308,380
Gross profit	237,937	182,428
Selling, general and administrative expenses	421,254	272,897
Operating income (loss)	(183,317)	(90,469)
Other income and (expense)
Gain recognized on purchase of majority interest in WCI	0	1,250,000
Interest income	2,389	0
Interest expense	(4,000)	(4,490)
Gain (loss) on investments	1,339	1,377
Other income (expense)	0	75
Total other income and (expense)	(272)	1,246,962
Income (loss) before provision for income taxes	(183,589)	1,156,493
Provision for income taxes	0	0
Net income (loss)	(183,589)	1,156,493
Gain (loss) attributable to non-controlling interest	24,120	16,888
Net income (loss) attributable to controlling interest	$ (207,709)	$ 1,139,605
Basic and diluted net income (loss) per common share:
Basic	$ (0.014)	$ 0.171
Diluted	$ 0	$ 0.171
Weighted average number of shares of common stock outstanding:
Basic	14,539,270	6,666,232
Diluted	0	6,670,732

XML

Convertible note receivable

3 Months Ended

Mar. 31, 2015

Convertible note receivable Text Block:

Convertible note receivable

Note 7 – Convertible note receivable

The Company advanced $100,000 to Electrum Partners, LLC (Electrum) as a convertible note receivable on March 12, 2014.  Accrued interest of $5,116 and $4,942 is included in the convertible note receivable balance at March 31, 2015 and December 31, 2014, respectively.  The note bears interest at 5% per annum, compounded monthly for the period from March 12, 2014 to September 12, 2015, at which point the interest will increase to 10% annual interest, compounded monthly until maturity or until it is converted to shares of equity in Electrum.  There are no payments required under the note for the period from March 12, 2014 to October 12, 2015; from October 12, 2015 to March 12, 2017 interest only payments are required; and from March 12, 2017 through March 12, 2022 payments of principal and interest in the amount of $2,289.83 per month are required.  Mentor has the option to convert the note plus any accrued interest or fees into shares of equity in Electrum at any time prior to its maturity.

XML

Property and equipment

3 Months Ended

Mar. 31, 2015

Property and equipment:

Property and equipment

Note 6 - Property and equipment

Property and equipment is comprised of the following at March 31, 2015 and December 31, 2014:

		March 31, 2015		December 31, 2014
Computers	$	15,187	$	15,187
Furniture and fixtures		20,712		19,491
Machinery and vehicles		179,375		179,375
Capitalized software		25,007		25,007
		240,281		239,060
Accumulated depreciation and amortization		(164,978)		(157,484)
Net Property and equipment	$	75,303	$	81,576

Depreciation and amortization expense was $7,493 and $9,460 for the three months ended March 31, 2015 and 2014, respectively.  

XML

Segment Information

3 Months Ended

Mar. 31, 2015

Segment Information:

Segment Information

Note 18 – Segment Information  

The Company is operating an acquisition and investment business.  Majority owned subsidiaries of 51% or more are consolidated.  The Company has determined that beginning in January 2014 there are two reportable segments, which are 1) the cannabis and medical marijuana segment which includes the receivable from Bhang of $1,500,000, the convertible note receivable from Electrum Partners and the operation of MCB, a subsidiary in the Cannabis and medical marijuana sector, and 2) the Company’s legacy investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their trash related operating costs.  The Company also has certain small cancer related legacy investments and an $117,000 investment in note receivable from a non-affiliated party that is included in Corporate below.  

		Cannabis and Medical Marijuana Segment		Legacy Investment		Corporate and Eliminations		Consolidated
Three months ended March 2015
Net sales	$	-	$	573 850	$	-	$	573,850
Income (loss) from operations		-		55 462		(245,316)		(183,317)
Total assets		1,626,740		1,114,834		1,140,954		3,882,528
Interest expense		-		4,774		(774)		4,000
Depreciation and amortization		-		6,810		683		7,493
Three months ended March 2014
Net sales	$	-	$	490,808	$	-	$	490,808
Income (loss) from operations		(21,551)		68,035		(136,953)		(90,469)
Total assets		1,600,927		1,122,564		1,270,899		3,994,390
Interest expense		-		4,093		397		4,490
Depreciation and amortization		-		6,091		3,369		9,460

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

		Three months ended March 31
		2015		2014
Operating income (loss)	$	(183,317)	$	(90,469)
Gain recognized on purchase of majority interest in WCI		-		1,250,000
Interest income		2,389		-
Interest expense		(4,000)		(4,490)
Gain on investments		1,339		1,377
Other income		-		75
Income before income taxes	$	(183,589)	$	1,156,493

XML

Long term debt and revolving line of credit

3 Months Ended

Mar. 31, 2015

Long term debt and revolving line of credit:

Long term debt and revolving line of credit

Note 14 – Long term debt and revolving line of credit  

Long term debt

		March 31, 2015		December 31, 2014
Two auto loans through Compass bank, interest at 7.99% per annum, monthly principle and interest payments of $538, maturing February 2016	$	5,688	$	7,168
Auto loan through Ford Credit, interest at 6.64% per annum, monthly principle and interest payments of $467, maturing October 2015		2,747		4,087
Auto loan through Hyundai Motor Finance, interest at 2.99% per annum, monthly principle and interest payments of $878, maturing December 2018.		36,538		38,905
Total notes payable		44,973		50,160
Less:  Current maturities		(17,988)		(18,911)
	$	26,985	$	31,249

Revolving line of credit

The Company has a $75,000 unsecured revolving line of credit with Bank of America, with interest at the bank’s prime rate plus 3% due monthly.  The line of credit matures on September 4, 2015.   At March 31, 2015 and December 31, 2014, the Company had $60,000 outstanding on the line of credit.  The line is secured by a personal guarantee of WCI’s president.

XML

Warrants redemption liability

3 Months Ended

Mar. 31, 2015

Warrants redemption liability:

Warrants redemption liability

Note 10 - Warrant redemption liability

The Plan of Reorganization provides the right for the Company to call, and the Company or its designee to redeem warrants that are not exercised timely, as specified in the Plan, by transferring a $0.10 redemption fee to the former holders. Certain individuals desiring to become a Company designee to redeem warrants have deposited redemption fees with the Company that, when warrants are redeemed, will be forwarded to the former warrant holders at their last known address 30 days after the last warrant of a class is exercised, or earlier at the discretion of the Company. The Company has arranged for a service to process the redemption fees in offset to an equal amount of liability.  

XML

Purchase of additional equity in WCI (Details) (USD $)	Mar. 31, 2015
Purchase of additional equity in WCI: {1}
Mentor purchased an additional interest in WCI	1.00%
Value of additional interest purchased in WCI	$ 25,000
Ownership in WCI	51.00%
Mentor remeasured its previously held equity interest at the acquisition-date fair value and recognized the resulting gain on investment	$ 1,250,964

XML

Long term investments and fair value

3 Months Ended

Mar. 31, 2015

Long term investments and fair value

Long term investments and fair value

Note 8 – Long term investments and fair value

The Company’s financial assets contained investments that have quoted market prices in active markets, the Company uses the quoted market prices as fair value and includes these prices in the amounts disclosed in Level 1 of the hierarchy. The Company receives the quoted market prices from a third party, nationally recognized pricing service (“pricing service”). When quoted market prices are unavailable, the Company utilizes a pricing service to determine a single estimate of fair value, which is mainly for its fixed maturity investments. The fair value estimates provided from this pricing service are included in the amount disclosed in Level 2 of the hierarchy. The Company bases all of its estimates of fair value for assets on the bid price as it represents what a third party market participant would be willing to pay in an arm’s length transaction.

The hierarchy of Level 1, Level 2 and Level 3 Assets are listed as following:

	Fair Value Measurements Using Unadjusted Quoted Market Prices (Level 1)	Fair Value Measurements Using Quoted Prices for Identical or Similar Assets in Active Markets (Level 2)	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Equity Securities	Other investment	Long-Term Equity Funding Agreements
Balance at December 31, 2013	21,320	10,000	55,943
Total gains or losses
Included in earnings (or changes in net assets)	1,303	1,410	-
Purchases, issuances, sales, and settlements
Purchases	18,846	-	-
Issuances	-	-	-
Sales	(35,637)	(1,150)	-
Settlements	-	-
Balance at December 31, 2014	5,832	10,260	55,943

	Fair Value	Fair Value	Fair Value
	Measurements	Measurements	Measurements
	Using	Using	Using
	Unadjusted Quoted Market Prices	Quoted Prices for Identical or Similar Assets in Active Markets	Significant Unobservable  nputs
	(Level 1)	(Level 2)	(Level 3)
	Equity Securities	Other investment	Long-Term Equity Funding Agreements
Total gains or losses
Included in earnings (or changes in net assets)	1,278	152	-
Purchases, issuances, sales, and settlements
Purchases	1,061	-	-
Issuances	-	-	-
Sales	(1,053)	-	-
Settlements	-	-
Balance at March 31, 2015	$                  7,118	$                 10,412	$                55,943

XML

Common stock warrants

3 Months Ended

Mar. 31, 2015

Common stock warrants:

Common stock warrants

Note 9 - Common stock warrants

The Company's Plan of Reorganization provided for the creditors and claimants to receive new warrants in settlement of their claims. In 2008, the term of the warrants, initially sixteen months, was extended by the Company until May 11, 2038. Management believes that identification of a specific expiration date was merely a formality and that this was not a material change from the automatic extensions which were initially provided for by vote of the board of directors and which were being performed annually since issuance, and also because the shareholders and warrant holders were primarily the same.  The Company recorded no accounting impact as a result of the extension.

Each warrant is callable by the Company if the share price exceeds the exercise price by the lesser of $1 or 100%. The warrant holders have a minimum of 30 to 90 calendar days during which to exercise their warrants once they are called. The Company may lower the exercise price of the warrants at any time.  Similarly, the Company could, but does not anticipate, reverse splitting the stock to raise the stock price above the warrant exercise price.  The warrants are specifically not affected and do not split with the shares in the event of a reverse split.  If the called warrants are not exercised, the Company has the right to designate the warrants to a new holder in return for a $0.10 per share redemption fee payable to the original warrant holder as discussed further in Note 10.  All such changes in the exercise price of series A, B, C and D warrants were provided for by the court in the Plan of Reorganization in order to provide a mechanism for debtors to receive value.  Therefore, Management believes that the act of lowering the exercise price is not a change from the original warrant grants and the Company has not recorded an accounting impact as the result of such change in exercise prices.

Exercise prices at December 31, 2012 and subsequent lower prices for the A, B, C and D warrants are as follow:

	Series A	Series B	Series C	Series D
December 31, 2012	$     1.00	$     3.00	$     0.65	$     7.00
March 21, 2012	$     0.09	$     3.00	$     0.65	$     7.00
August 21, 2012	$     0.09	$     0.11	$     0.65	$     7.00
April 1, 2013	$     0.01	$     0.11	$     0.09	$     7.00
June 18, 2014	$           -	$     0.11	$           -	$     1.60

At November 8, 2009, the Company entered into an Investment Banking agreement with Network One Securities, LLC and a related Strategic Advisory Agreement with Lenox Hill Partners, LP with regard to a potential merger with a cancer development company.  In conjunction with those related agreements, the Company issued 81,699 Series E ($1) Warrants, 369,037 Series F ($3) Warrants, 85,579 Series G ($0.65) Warrants and 689,159 Series H ($7) Warrants, all with a 30 year life.  The warrants are subject to cashless exercise based upon the ten day trailing closing bid price preceding the exercise as interpreted by the Company.   The fair value of the warrants issued under the agreements was estimated on the date of the issuance using the Black-Scholes option pricing model.  The use of a valuation model requires the Company to make certain assumptions with respect to selected model inputs.  Expected volatility was calculated based on the historical volatility of the Company’s stock price.  The average expected life is based on the contractual term of the warrant and expected exercise behavior.  The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant.  

The following table provides the assumptions used to value the options granted and warrants issued using the Black-Scholes option pricing model:

	Series E	Series F
	and G	and H
Stock price volatility	111.60%	111.60%
Risk-free rate of return	4.26%	4.26%
Annual dividend yield	0.00%	0.00%
Expected life (in years)	0.5	3.0

As of March 31, 2015 and December 31, 2014 the weighted average contractual life for all Mentor warrants was 21.4 years and 23.4 years, respectively, and the weighted average outstanding warrant exercise price was $1.84 and $1.84 per share, respectively.

During the three months ended March 31, 2015 and 2014, a total of 1,187,847 and 8,006,696 warrants were exercised, respectively. There were no warrants issued during the periods ended March 31, 2015 and 2014.  The intrinsic value of outstanding warrants at March 31, 2015 and 2014 was $2,835 and $15,300, respectively.

The following table summarizes common stock warrants as of each period:

	Series A	Series B	Series C	Series D	A,B,C,D Total Warrants
Outstanding at December 31, 2013	1,188,909	5,332,981	128,180	15,312,627	21,962,697
Issued	-	-	-	-	-
Exercised	(1,188,909)	(5,328,481)	(128,180)	(807,861)	(7,453,431)
Outstanding at December 31, 2014	-	4,500	-	14,504,766	14,509,266
Issued	-	-	-	-	-
Exercised	-	-	-	(226,740)	(226,740)
Outstanding at March 31, 2015	-	4,500	-	14,278,026	14,282,526

Series E, F, G and H warrants were issued for investment banking and advisory services during 2009.  The following table summarizes E, F, G and H warrants as of each period:

	Series E    $1.00 exercise   price	Series F $3.00 exercise price	Series G  $0.65 exercise price	Series H  $7.00 exercise price	E,F,G,H Total Warrants
Outstanding at December 31, 2013	107,931	369,037	88,579	689,159	1,254,706
Issued	-	-	-	-	-
Exercised	(107,931)	(369,037)	(88,579)	-	(565,547)
Outstanding at December 31, 2014	-	-	-	689,159	689,159
Issued	-	-	-	-	-
Exercised	-	-	-	-	-
Outstanding at March 31, 2015	-	-	-	689,159	689,159
Shares issued in 2014 as a result of cashless exercise	73,388	210,870	70,152	-	354,410

On February 9, 2015, in accordance with the authorizing section 1145 reorganization court order, the Company announced a 30 day partial redemption of up to 1% (approximately 140,000) of the already outstanding series D warrants to provide for the court specified redemption mechanism for warrants not exercised timely by the original holder or their estates. Company designees that apply during the 30 days must pay 10 cents to redeem the warrant and then exercise the series D warrant to purchase a share at $0.435, which follows the court specified formula of one-half of the closing bid price on the day preceding the 30 days, plus the 10 cent fee. In successive months, the 1% partial redemption authorization will be recalculated and repeated according to the court formula until such unexercised warrants are exhausted or the partial redemption is otherwise truncated by the Company.  

XML

Funding Agreement

3 Months Ended

Mar. 31, 2015

Funding Agreement:

Funding Agreement

Note 11 - Funding agreement

The Company entered into a co-operative funding agreement with MCB that closed on February 18, 2014, to purchase up to a 51% interest in MCB.  MCB provides cannabis and marijuana related private companies, investors and microcap issuers with information resources including client company specific publications, directories, and continuing education courses.   MCB was to receive up to $200,000 in funding as Mentor receives proceeds from warrant exercise.  Allocation of funding to MCB is discretionary and could be reduced to $100,000 with no change in Mentor’s ownership if Mentor is dissatisfied with MCB performance.  Subsequent to March 31, 2015, MCB was notified that the funding would be reduced to $100,000, see Note 19.  The Company has the right, in its sole discretion, to convert the paid portion of the $100,000 equity investment in MCB to a six percent (6%) ten-year note payable to Mentor by the majority owner of MCB in 120 equal payments of principal and interest at any time.  If triggered, this provision would truncate further funding.  Subsequent to March 31, 2015, Mentor notified MCB that it was exercising its right to convert its equity to a ten-year note, see Note 19.

XML

Loans commitment fee receivable (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Loans commitment fee receivable Details
Company paid for credit default insurance to a third party as required by the lender on an international loan facility.		$ 621,250
Amount represented percent of prospective loan amount		1.75%
The amount was expensed as loan costs in the consolidated statement of operations for the year	$ 621,250

XML

Reconciles operating segments and corporate-unallocated operating income (loss) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Reconciles operating segments and corporate-unallocated operating income (loss) Details
Operating income (loss)	$ (183,317)	$ (90,469)
Gain recognized on purchase of majority interest in WCI	0	1,250,000
Interest income	2,389	0
Interest expense	(4,000)	(4,490)
Gain on investments	1,339	1,377
Other income	0	75
Income before income taxes	$ (183,589)	$ 1,156,493

XML

Commitments and contingencies (Details) (USD $)	Aug. 11, 2014
Mentor lawsuit seeking rescission of co-operative funding agreement with Bhang Details:
Mentor filed suit against Bhang and its owners in the United States District Court for the Northern District of California for rescission of the February 28, 2014 co-operative funding agreement with Bhang, seeking return of the investment	$ 1,500,000

XML

Schedule of an outstanding liability to its Chief Executive Officer ("CEO") as follows (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of an outstanding liability to its Chief Executive Officer ("CEO") as follows (Tables):

Schedule of an outstanding liability to its Chief Executive Officer ("CEO") as follows (Tables)

As of March 31, 2015 and December 31, 2014, the Company had an outstanding liability to its Chief Executive Officer ("CEO") as follows:

		March 31,     2015		December 31, 2014
Accrued salaries and benefits	$	721,987	$	716,055
Accrued incentive fee and bonus		190,581		190,581
Accrued retirement and other benefits		441,917		439,751
Offset by shareholder advance		(1,049,331)		(1,073,405)
	$	305,154	$	272,982

XML

Warrant redemption liability (Details) (USD $)	Mar. 31, 2015
Warrant redemption liability Details
Prepaid warrant liability	$ 0
Transferring redemption fee to the former holders	$ 0.10

XML

Purchase of additional equity in WCI

3 Months Ended

Mar. 31, 2015

Purchase of additional equity in WCI:

Purchase of additional equity in WCI

Note 16 - Purchase of additional equity in WCI

Effective January 1, 2014, Mentor purchased an additional 1% interest in WCI for $25,000 which resulted in a 51% ownership in WCI.  In 2013 Mentor’s investment in WCI was recorded under the equity method.  In accordance with Accounting Standard Codification 810-10, Consolidation – Overall, Mentor remeasured its previously held equity interest at the acquisition-date fair value and recognized the resulting gain of $1,250,964 on investment in subsidiary which is included in other income and expense in the consolidated statement of operations.

Cash to acquire additional 1% equity interest in WCI	$	25,000
Fair value of 50% interest (a)		1,250,000
Investment under equity method		-
Total purchase price to be allocated	$	1,275,000

(a) Estimated fair value of Mentor’s previously-held equity interest in WCI is valued at 1.25 times WCI’s projected 2014 revenue.

Purchase price allocation at 51% of WCI assets and liabilities:

WCI assets and liabilities:
Current assets	$	327,238
Property and equipment		51,239
Other assets		816,952
Current liabilities		(112,810)
Long-term debt		(1,178,977)
Net deficit		(96,358)
Mentor equity rate		51%
Mentor portion of liabilities in excess of assets		(49,143)
Goodwill		1,324,143
Net assets acquired	$	$1,275,000

XML

Schedule of Prepaid expense and other assets (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Prepaid expense and other assets (Tables):

Schedule of Prepaid expense and other assets

Prepaid expenses and other assets consist of the following:

		March 31, 2015		December 31, 2014
Prepaid advertising costs	$	3,637	$	27,708
Prepaid legal fees		9,145		9,145
Other prepaid costs		28,218		28,218
	$	41,000	$	55,655

XML

Summary of Common Stock Warrants - A, B, C, D (Details)	Series A	Series B	Series C	Series D	A,B,C,D Total Warrants
Outstanding at Dec. 31, 2013	1,188,909	5,332,981	128,180	15,312,627	21,962,697
Issued	0	0	0	0	0
Exercised	(1,188,909)	(5,328,481)	(128,180)	(807,861)	(7,453,431)
Outstanding at Dec. 31, 2014	0	4,500		14,504,766	14,509,266
Issued	0	0	0	0	0
Exercised	0	0	0	(226,740)	(226,740)
Outstanding at Mar. 31, 2015	0	4,500	0	14,278,026	14,282,526

XML

Investment in account receivable (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Investment in account receivable consists of the following
Face value	$ 0	$ 117,000
Unamortized discount	0	(2,250)
Net balance	$ 0	$ 114,750

XML

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (183,589)	$ 1,156,493
Adjustments to reconcile net income (loss) to net cash provided by (used by) operating activities:
Depreciation and amortization	7,494	9,459
Amortization of discount on investment in account receivable	(2,250)	0
Change in unrealized gain on securities	0	0
Accrued investment interest income	(326)	0
Gain recognized on purchase of majority interest in WCI	0	(1,250,000)
Decrease (increase) in operating assets
Accounts receivable - trade	(838)	22,499
Prepaid expenses and other current assets	14,655	176,990
Increase (decrease) in operating liabilities
Accounts payable	(11,303)	(22,832)
Accrued expenses	(18,750)	31,210
Income tax payable	0	0
Accrued salary, retirement and benefits - related party	32,171	(150,899)
Net cash provided by (used by) operating activities	(162,736)	(27,080)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(1,221)	(3,443)
Investment in securities	(2,347)	(3,319)
Proceeds from investment in securities	1,053	0
Receivable - Bhang Chocolate Company shareholders	0	(800,000)
Receipt of investment in receivable	117,000	0
Investment in convertible note receivable	0	(100,000)
Proceeds from long term investment	0	1,150
Effect of consolidating WCI on January 1, 2014, net of cash	0	(45,921)
Employee advances repaid	1,200	1,354
Net cash provided by (used by) investing activities	115,694	(950,179)
CASH FLOWS FROM FINANCING ACTIVITIES:
Warrants converted to common stock, net of costs	99,855	3,056,120
Payments on long-term debt	(5,187)	(10,175)
Contribution by subsidiary minority interest	0	8,300
Distribution to non-controlling interest	(25,060)	(3,210)
Shares retired	0	(161)
Net cash provided by (used by) financing activities	69,608	3,050,874
Net change in cash	22,566	2,073,614
Beginning cash	326,228	40,184
Ending cash	348,794	2,113,798
SUPPLEMENTARY INFORMATION:
Cash paid for interest	1,852	4,000
Cash paid for income taxes	0	0
NON-CASH INVESTING AND FINANCING TRANSACTION:
Shareholder exercise of warrants by decrease in Liability to shareholder	0	433,851
Shareholder assumption of warrant liability resulting in Increased liability to shareholder	$ (24,074)	$ 0

XML

Investment in account receivable

3 Months Ended

Mar. 31, 2015

Investment in account receivable:

Investment in account receivable

Note 5 – Investment in account receivable

The investment in account receivable is supported by a promissory note which matured January 15, 2015 and consists of the following:

		March 31, 2015		December 31, 2014
Face value	$	-	$	117,000
Unamortized discount		-		(2,250)
Net balance	$	-	$	114,750

The note was paid and extinguished in March 2015.  For the three months ended March 31, 2015 and 2014, $2,250 and $0 of discount amortization is included in interest income.  

XML

Revolving line of credit (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Revolving line of credit:
Company has an unsecured revolving line of credit with Bank of America	$ 75,000
Interest at bank's prime rate	3.00%
Company had outstanding on the line of credit secured by a personal guarantee of WCI's president	$ 60,000	$ 60,000

XML

Schedule of Investment in account receivable (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Investment in account receivable (Tables):

Schedule of Investment in account receivable (Tables)

The investment in account receivable is supported by a promissory note which matured January 15, 2015 and consists of the following:

		March 31, 2015		December 31, 2014
Face value	$	-	$	117,000
Unamortized discount		-		(2,250)
Net balance	$	-	$	114,750

XML

Nature of operations (Narrative) (Details) (USD $)	Mar. 31, 2015
Nature of operations Details
Mentor purchased an additional 1% interest in Waste Consolidators, Inc	$ 25,000
Mentor purchased an additional 1% interest in Waste Consolidators, Inc which resulted in a ownership	51.00%
Signed an agreement to purchase a 51% interest in MicroCannaBiz, LLC	$ 200,000
Acquired ownership in Bhang Chocolate Company, Inc.	60.00%

XML

Accrued salary, accrued retirement and related party incentive fee

3 Months Ended

Mar. 31, 2015

Accrued salary, accrued retirement and related party incentive fee

Accrued salary, accrued retirement and related party incentive fee

Note 15 - Accrued salary, accrued retirement and related party incentive fee

As of March 31, 2015 and December 31, 2014, the Company had an outstanding liability to its Chief Executive Officer ("CEO") as follows:

		March 31,     2015		December 31, 2014
Accrued salaries and benefits	$	721,987	$	716,055
Accrued incentive fee and bonus		190,581		190,581
Accrued retirement and other benefits		441,917		439,751
Offset by shareholder advance		(1,049,331)		(1,073,405)
	$	305,154	$	272,982

The Company agreed to advance the CEO $944,000 against the accrued liabilities due him, in January 2014, to exercise additional warrants into shares to be used as collateral for a potential loan to the Company.  The warrant exercise was a cashless transaction made solely for the benefit of the Company in its efforts to obtain financing.   

After the warrants were exercised, the CEO put 100% of his shares owned, 5,000,486 shares, in an escrow which was to guarantee the potential loan.  The loan was mutually rescinded on June 12, 2014, and the shares remain in escrow as of the audit date.  The CEO must make a public press release and post a notice on the Mentor website before he removes the shares from escrow.

As provided by Board of Director resolution in 1998, the CEO will be paid an incentive fee and a bonus which are payable in cash upon merger, resignation or termination or in installments at the CEO’s option.  The incentive fee is 1% of the increase in market capitalization based on the bid price of the Company’s stock beyond the book value at confirmation of the bankruptcy, which was approximately $260,000.  The bonus is 0.5% of the increase in market capitalization for each $1.00 increase in stock price up to a maximum of $8 per share (4%) based on the bid price of the stock beyond the book value at confirmation of the bankruptcy.  The Company recorded $0 of accrued incentive fee and bonus for each of the three months ended March 31, 2015 and 2014.